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ABSTRACT 
The central nervous system has very limited ability to repair itself after injury but has been shown to 
exhibit remarkable experience-driven structural plasticity at the synaptic level. These changes correlate 
strongly with behavioral performance and are thought to underlie learning and memory. MAG, OMgp 
and Nogo are a group of neurite growth inhibitors present in CNS myelin and exerting effects by binding 
to a common receptor, NgR1. Because Nogo is also expressed by neurons and NgR1 is exclusively 
expressed in neurons and downregulated by activity, NgR1 may regulate plasticity. For local synaptic 
plasticity to occur one requirement could be that NgR1 signaling decreases. In fact, NgR1 is rapidly 
downregulated in key areas associated with plasticity such as hippocampus in a variety of different 
models of neuronal activity. When NgR1 is knocked out, mice show increased plasticity and continue to 
demonstrate ocular dominance shift plasticity in the visual cortex into adulthood.  
The aim of this thesis was to further investigate how the Nogo-system is regulated and to 
evaluate how it may influence memory formation. It is confirmed that increased neuronal activation 
(using Kainic acid) causes rapid downregulation of NgR1 and a more detailed time course of this effect is 
presented. The NgR1 downregulation might be further potentiated through an increase of the endogenous 
NgR1 antagonist LOTUS in the dentate gyrus. In contrast to NgR1, both NgR2 and NgR3 were mostly 
upregulated following Kainic acid injection. As the spectrum of known ligands for the different NgRs 
differ, this could result in a change in responsiveness to different inhibitor types and might favor 
increased local plasticity while keeping plasticity at the level of non-terminal axons and main dendrites in 
check.  
We created a mouse with inducible overexpression of NgR1 in forebrain neurons 
(MemoFlex) to test the hypothesis that reduced NgR1 levels are important for memory formation. We 
found that while NgR1 overexpression does not impair 24 h memory and day to day learning, it 
significantly impairs formation of lasting memories as shown in both the Morris water maze and a 
passive avoidance test. By turning the NgR1 transgene off (by doxycycline) at different time points, we 
were able to demonstrate that NgR1 downregulation-dependent memory consolidation occurs during the 
first 7-9 days after a memory-forming event. MemoFlex mice exhibited increased sensitization to 
amphetamine (that could be normalized by turning off the transgene), as if they were unable to "learn" 
and hence cope with amphetamine injections lasting for as long as a week. When retested after 110 days 
MemoFlex mice showed a significant reduction of "sensitization memory" compared to their 
performance at the end of the sensitization period. Control mice tended to increase sensitization during 
the withdrawal period. Mice lacking NgR1 did not differ from control mice with respect to a week-long 
amphetamine sensitization. Analysis of spine density and subtypes in the cingulate gyrus and the shell of 
nucleus accumbens indicated that NgR1 overexpression has significant effects on spine dynamics.  
NgRs have also been shown to affect the deposition and formation of Aβ-plaques in mouse models of 
Alzheimer’s disease. To test if NgR1 overexpression would affect plaque deposition we crossed 
MemoFlex mice with plaque-forming APPswe/PSEN1 mice. While we could not see any significant 
change in plaque formation in APPswe/PSEN1 mice with NgR1 overexpression, they were significantly 
impaired in the Morris water maze. The fact that performance was significantly decreased while plaque 
formation was unaffected could result from impairment of compensatory synaptic plasticity that 
otherwise occur in plaque-forming mice.  
Taken together, these studies suggest a role for the Nogo-system, and in particular 
NgR1, for the formation of lasting memories. 
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INTRODUCTION  
A phenomenon that has received a substantial amount of attention within the field of 
neuroscience is the fact that the central nervous system (CNS) is highly inhibitory to 
neuronal outgrowth and regeneration. It has been long known from transplantation 
experiments that CNS neurons can extend neurites into grafts from the peripheral 
nervous system (PNS) (Benfey and Aguayo, 1982; Richardson et al., 1984; So and 
Aguayo, 1985). This is interesting as it shows that CNS neurons possess the ability to 
grow but require a different environment to be able to do so. In contrast, PNS neurons 
that have been shown to exhibit rather good regeneration lose this function when 
exposed to material from the CNS (Aguayo et al., 1978; Weinberg and Spencer, 1979). 
Hence while PNS appears to enhance neuronal outgrowth, the CNS instead actively 
impairs it.  
 
NERVE GROWTH INHIBITORY MOLECULES OF CNS MYELIN 
In 1988 it was shown that two protein fractions of 35 and 250 kDa found in CNS 
myelin (but not in PNS myelin) were inhibitory for neuronal outgrowth (Caroni and 
Schwab, 1988b). It was also shown that two antibodies, IN-1 and IN-2, raised against 
the 250 kD and 35 kD protein respectively, could bind to both the 35 and the 250 kDa 
fragment (suggesting that they share a functional domain) and counteract the inhibitory 
effect of CNS myelin (Caroni and Schwab, 1988a). It was for instance shown that 
neurons in optic nerve explants could grow over 3 mm, something that only occurred 
occasionally when a control antibody was used. The inhibitory substance isolated from 
myelin, Nogo, was cloned in 2000 (Chen et al., 2000; GrandPre et al., 2000; Prinjha et 
al., 2000) using a sequence from proteolytically digested Nogo published earlier 
(Spillmann et al., 1998). Nogo is a member of the Reticulon family and exists in 3 
different isoforms, Nogo-A, B and C. Of these isoforms Nogo-A has the most specific 
expression in CNS, while Nogo-B and C are also strongly expressed in other tissues. 
For instance, Nogo-B has been shown to have effects in endothelial cells (Acevedo et 
al., 2004; Miao et al., 2006; Yu et al., 2009) while the functions of Nogo-C are less 
well documented. Another neuronal outgrowth inhibitor, Myelin-associated 
glycoprotein (MAG), was identified early and found to be highly expressed in myelin 
(McKerracher et al., 1994; Mukhopadhyay et al., 1994). 
 
Nogo-A (by far the most studied form) contains an extracellular loop, Nogo-66 
(Consisting of 66 amino acids) (GrandPre et al., 2000) that can mediate part of the 
inhibitory effects of Nogo-A. Apart from the effects of Nogo-66, the N-terminal part of 
Nogo is also a potent inhibitor of outgrowth. Thus antibodies that bind to the N-
terminal part of Nogo-A can decrease the outgrowth inhibitory effects of Nogo-A 
(Chen et al., 2000; Oertle et al., 2003) and expression of only the N-terminal part was 
found to be inhibitory for outgrowth (Prinjha et al., 2000). It was recently shown that 
the inhibitory domain Nogo-A Δ20 (in the central Nogo-A specific region) can be 
internalized and be retrogradely transported to the cell body and there affect RhoA and 
CREB activity (Joset et al., 2010). Nogo-A was first identified as an inhibitor 
preferentially expressed in myelin but later studies showed that it was also expressed in 
neurons in several regions of both the maturing and adult CNS. These regions include 
the cerebral cortex and the hippocampus (Huber et al., 2002; Josephson et al., 2001; 
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Lee et al., 2008; Wang et al., 2002c), supporting a role for Nogo-A not only in myelin-
neuron interaction but also in neuron-neuron interaction. A third myelin associated 
inhibitor (MAI) was later identified and named Oligodendrocyte Myelin glycoprotein 
(OMgp) (Kottis et al., 2002).    
 
THE NOGO-66 RECEPTOR 
The first receptor for Nogo-A was found by screening for proteins that could bind to 
the Nogo-66 domain (Fournier et al., 2001) and was therefore named the Nogo-66 
receptor (NgR), While Nogo-66 is sufficient to induce binding, the affinity can be 
increased further by including parts of the C-terminal domain of Nogo-A (Hu et al., 
2005) and inhibition by NgR1 is more potent when a longer fragment (Nogo-22) is 
used instead of Nogo-66 (Huebner et al., 2011). It was later shown that there are two 
homologous Nogo receptors now commonly referred to as NgR2 and NgR3 (Barton et 
al., 2003; Lauren et al., 2003; Pignot et al., 2003). Hence what used to be called NgR is 
now most often referred to as NgR1.  NgR1 was shown to consist of a signal sequence 
followed by 8 leucine rich repeats (LRR) domains, a LRR carboxy terminal flanking 
domain with a final unique region containing a GPI anchor (Fournier et al., 2001). 
Shortly after the discovery that NgR1 could mediate some of the inhibitory effects of 
Nogo-A it was also shown that MAG can bind to and induce growth cone collapse 
through NgR1 (Domeniconi et al., 2002; Liu et al., 2002). MAG had previously been 
shown to induce RhoA activation through p75 (Yamashita et al., 2002) and it was 
suggested that this could possibly involve sialic acid dependent binding of MAG to the 
gangliocide GT1b. However in the studies identifying NgR1 as a receptor for MAG it 
was shown that MAG binding to NgR1 was sialic acid independent (Domeniconi et al., 
2002; Liu et al., 2002); this together with the fact that the inhibitory function of MAG 
was diminished after treatment with PI-PLC suggested that binding to GT1b was not 
required for MAG function (however the independence of sialic acid has been 
questions (Robak et al., 2009)). Of note, the two papers did however come to different 
conclusions concerning if MAG and Nogo-66 competed in binding to NgR1. One paper 
showed a dose dependent decrease of binding of MAG (Domeniconi et al., 2002) with 
increasing concentrations of Nogo-66 and the other paper showed no effect (Liu et al., 
2002). In a screen to identify GPI-linked myelin inhibitors, OMgp was shown to be 
able to bind to NgR1 (Wang et al., 2002b) and similarly to Nogo and MAG, OMgp can 
signal through NgR1 and induce growth cone collapse (Wang et al., 2002b). While it is 
clear that MAIs can induce growth cone collapse by binding to NgR1, the roles of 
MAIs on nerve fiber growth and other aspects of axon functions are not fully 
understood (Chivatakarn et al., 2007; Huebner et al., 2011).  
 
Following the discovery of the myelin-derived ligands, NgR1 has been shown to bind 
to several other ligands. For instance, NgR1 can bind to B-lymphocyte stimulator 
(BLYS), part of the immune system, shown to have inhibitory effects on neurite 
outgrowth from dorsal root ganglion neurons (Zhang et al., 2009). Furthermore, NgR1 
appears to be involved in EGFR signaling and its effects on neuronal outgrowth 
(Koprivica et al., 2005). However, little is known about the significance of that 
interaction. The function of NgR1 receptor signaling was further complicated when it 
was shown that phosphorylation of NgR1 by extracellular casein kinase 2 makes it 
unable to bind to MAG, OMgp or Nogo-66 (Takei, 2009).  
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ENDOGENOUS NGR1 INHIBITORS 
NgR1 function is not only modulated by the different activating ligands discussed 
above. It has been shown that the nervous system expresses several endogenous NgR1 
antagonists. The first such endogenous inhibitor of Nogo-66 - NgR1 signaling to be 
found was Leucine-rich glioma inactivated 1 (LGI1) (Thomas et al., 2010). It was also 
shown that NgR1 could enhance the binding of ADAM22 to LGI1. This suggests a new 
pathway through which NgR1 could influence synaptic plasticity as LGI1 and 
ADAM22 interaction have been shown to affect dendritic pruning and synaptic 
function (Fukata et al., 2006; Zhou et al., 2009).  
 
Searching for molecules that could affect the development of the lateral olfactory tract 
it was found that Lateral Olfactory Tract Usher Substance (LOTUS) could inhibit the 
binding of Nogo-A to NgR1. Thereby local Nogo-NgR1 growth inhibition can be 
blocked (Sato et al., 2011), as mediated through the C-terminal domain of LOTUS 
(Kurihara et al., 2012). 
 
Another inhibitor of NgR1 is the secreted protein Olfactomedin 1 (Nakaya et al., 2012), 
that is able to decrease the binding of NgR1 to its co-receptor and thereby inhibit NgR1 
function. The expression of Olfactomedin 1 co-localizes with that of NgR1 in the 
dentate gyrus and CA3 of the hippocampus, both areas shown to be highly plastic. This 
raises the possibility that secretion of Olfactomedin 1 can be one way to overcome 
NgR1 induced growth inhibition. Thus far, these three inhibitors appear to be specific 
for NgR1 and not affect the other NgRs.  
 
NGR1 AND ITS CO-RECEPTORS 
As NgR1 is attached to the cell membrane by a GPI link, it lacks a cytoplasmic domain 
and requires co-receptors to transduce a signal into the cell. The first co-receptor to be 
identified for NgR1 was the low affinity-neurotrophin receptor p75 (Wang et al., 
2002a) and it was shown that together with NgR1, p75 could mediate effects of Nogo-
A, MAG and OMgp (without affecting the affinity with which these ligands bind to 
NgR1). When MAG was added to the binding assay the interaction between NgR1 and 
p75 increased, suggesting that when a ligand binds to NgR1 it increases its affinity for 
p75 (Wang et al., 2002a). In the same year it was shown that when MAG binds to p75 
the activity of RhoA will increase (Yamashita et al., 2002) and subsequent studies have 
continued to implicate RhoA as a downstream effector of Nogo-signaling (reviewed in 
(Nash et al., 2009)). It was later shown that while NgR1 and p75 could induce growth 
cone collapse in several different cell types, in some it required a second co-receptor to 
function in the form of Lingo-1 (Mi et al., 2004), possibly assisted by gangliosides 
(Saha et al., 2011). Lingo-1 is specifically expressed in neurons of the CNS and the 
expression decreases caudally and overlaps well with the expression of NgR1 (Barrette 
et al., 2007; Josephson et al., 2002). The expression of Lingo-1 is high around birth and 
decreases until prenatal day 8 (P8) but the expression remains substantial and stays at a 
similar level as that seen at day 8 into adulthood. Compared with the expression of 
Lingo-1 and NgR1, the expression of p75 is rather limited and several neuronal sub-
types that are strongly inhibited by myelin do not express p75 (Chao, 2003; Roux and 
Barker, 2002). In 2005 two groups published studies that identified TROY (Park et al., 
2005; Shao et al., 2005) as a new co-receptor for NgR1. TROY (Tumour necrosis 
factor-α (TNFα) receptor superfamily member 19) was found to be able to form a 
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complex with NgR1 and Lingo-1 even without p75. NgR1/Lingo-1/TROY expressing 
Cos7 cells induce RhoA activation in a similar manner as NgR1/Lingo-1/p75 cells, 
suggesting that TROY can replace the function of p75. Furthermore, overexpression of 
full length TROY in insensitive p75-/- neurons made them sensitive to growth cone 
collapse by Nogo-66 (Park et al., 2005). Of note, while p75 expression is high 
prenatally, the expression decreases sharply around birth. In contrast, TROY is 
expressed at rather high levels until p8, and drops to somewhat lower levels but retains 
higher expression than p75 into adulthood. This correlated much better with the 
expression patterns of Lingo-1 and NgR1 (Shao et al., 2005). In both studies TROY 
was found in neuronal cells of the CNS (Park et al., 2005; Shao et al., 2005). A later 
study investigating TROY expression in the developing and postnatal CNS found that 
TROY was mainly expressed in radial glia like cells during development and in 
astrocytes but not in post natal neurons (Hisaoka et al., 2006). Barrette and colleagues 
(Barrette et al., 2007) showed, using in situ hybridization, very low expression of 
TROY in most regions of CNS except for the hippocampal formation (but not in the 
dentate gyrus), islands of Calleja, laterodorsal tegmental nucleus and zona incerta. 
Hence it is still possible that more co-receptors remain to be found for NgR1.  
 
NGR2 AND NGR3 
There are two homologous receptors to NgR1, NgR2 and NgR3; that show largely 
overlapping expression patterns with NgR1 but with some significant differences 
(Barrette et al., 2007; Lauren et al., 2003; Pignot et al., 2003). For instance, NgR2 
shows significant mRNA expression in striatum (caudate nucleus) which is not true for 
NgR1 or NgR3 (however NgR1 protein (Venkatesh et al., 2005) is expressed in 
striatum, possibly in axons projecting from other NgR1 expressing areas). NgR3 lacks 
or has a very low expression in diencephalon while both NgR1 and NgR2 exhibit 
significant expression. Even though NgR2 and NgR3 show a strong homology to 
NgR1, their binding affinity to myelin inhibitors is significantly different. NgR2 shows 
no affinity for Nogo-A and OMgp but can bind to MAG with high affinity (Lauren et 
al., 2007; Robak et al., 2009; Venkatesh et al., 2005). NgR3 on the other hand, lacks 
affinity for any of the three myelin inhibitors (Venkatesh et al., 2005). NgR2 has also 
been shown to bind to Fbs1, an ubiquitin ligase associate protein (Kern et al., 2012). 
The functional relevance of this interaction is yet to be determined but could suggest a 
way to regulate NgR2 protein levels. While NgR3 lacks affinity to MAG, OMgp and 
Nogo, it can bind to chondroitin sulfate proteoglycans (CSPG) (Dickendesher et al., 
2012) and this is also true for NgR1. CSPGs are a large family of extra cellular matrix 
proteins that have been shown to be inhibitory to neuronal outgrowth at least partly 
through activation of RhoA. The formation and deposition of extracellular CSPGs 
increases after injury, especially in astrocytes that help to form a glial scar around the 
injury. 
 
STRUCTURE OF NGR1 AND LIGAND BINDING 
An in-depth characterization of ligand binding to NgR1 and NgR2 was carried out by 
Laurén and colleagues (Lauren et al., 2007) and confirmed the previous finding that 
NgR1 can bind to OMgp, MAG and Nogo-66 and that MAG could bind to NgR2 with 
high affinity. On NgR1 the core binding site of all three myelin associated inhibitors 
was found on the concave side of the LRR domain that had previously been shown to 
be required for ligand binding. There was some difference in binding sites between the 
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different ligands so that while the core domain is similar, the exact interaction between 
the different inhibitors appears to differ.  
 
EXPRESSION OF MYELIN INHIBITORS AND RECEPTORS  
Barrette and colleagues (Barrette et al., 2007) analyzed the expression of receptors for 
myelin inhibitors in CNS of mice and together with previous studies (Hunt et al., 2002; 
Josephson et al., 2002; Zheng et al., 2005) gives an overall consistent picture of the 
expression patterns of these molecules. NgR1 is expressed in large parts of the 
telencephalon with the most notable exceptions being striatum and the septal region. In 
diecephalon the expression is high in thalamus while expression was not detected in 
hypothalamus. In the brainstem NgR1 expression is more limited but present in several 
areas that project to the spinal cord.   
 
NgR2 is expressed in almost all areas where NgR1 is expressed with the biggest 
exception being the islands of Calleja (no NgR2 expression) and striatum (no NgR1 
expression) where expression patterns differ. Lingo-1 has an almost ubiquitous 
expression in the brain and covers all areas that show expression of NgR1 and NgR2. It 
is also expressed in areas without Nogo-receptors (Barrette et al., 2007; Okafuji and 
Tanaka, 2005), suggesting that it might have functions outside of myelin mediated 
outgrowth inhibition. The expression of both p75 and TROY is rather limited compared 
to NgR1, NgR2 and Lingo-1 and they are not expressed (or expressed at very low 
levels) in large areas of the cerebral cortex. Expression is also lacking in most of 
diencephalon and the brain stem.  
 
 Nogo-A is strongly expressed in myelin throughout life. When it comes to neuronal 
expression of Nogo-A, it is rather strong during development and decreases in 
adulthood. However, expression remains high in some neuronal populations such as 
those of the olfactory bulb, pyramidal neurons in cortex and neurons of the 
hippocampus (Huber et al., 2002; Hunt et al., 2003; Hunt et al., 2002; Josephson et al., 
2001; Mingorance et al., 2004). As all these regions are known for being highly plastic, 
the high expression of Nogo-A in these regions is interesting. The cellular distribution 
of Nogo-A was analyzed by Wang and colleagues (Wang et al., 2002c) and Nogo-A 
was found to be expressed both in the outer circumference of myelin sheaths and in the 
inner adaxonal membrane, while NgR1 protein was not found in myelin but was 
specific to neurons.  It has also been shown that all iso-forms of Nogo (A,B,C) are 
expressed on the cell surface and that they can interact with each other (Dodd et al., 
2005). NgR1 protein has been found both pre- and postsynaptically, there were no 
examples of a synapse with NgR1 at both the pre- and postsynaptic membrane; 
suggesting that pre- or postsynaptic distribution of NgR1 is regulated (Wang et al., 
2002c). Nogo-A in neurons is found in the synapses and similarly to NgR1 it exists 
both pre- and post synaptically (Lee et al., 2008; Liu et al., 2003; Wang et al., 2002c).  
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THE NOGO-SYSTEM AND CNS INJURY 
There has been a substantial amount of research examining the effects of the Nogo-
system and how it can affect neuronal outgrowth after injury.  Most of the initial 
research was on neuronal outgrowth following spinal cord injury. More recently, 
studies in stroke models have been carried out. 
 
REGROWTH AFTER INJURY/TRAUMA 
In studies examining the role of the Nogo-system in CNS injury, two different 
strategies have been used, based on the administration of inhibitors (around the time of 
damage) or the use of knock out animals (removing specific proteins, usually from 
birth). Several studies have shown increased neuronal outgrowth following spinal cord 
injury when blocking NgR1 function (Li and Strittmatter, 2003; Wang et al., 2006; 
Wang et al., 2011; Wang et al., 2012). However, even though neurons of the 
corticospinal tract (CST) express NgR1 it does not appear to regenerate better in NgR1-
/- mice (Kim et al., 2004; Zheng et al., 2005) while raphespinal and rubrospinal fibers 
do (Kim et al., 2004). Enhanced growth was also seen in NgR1-/- animals in an ocular 
crush model (Wang et al., 2012), especially when combined with zymosan 
(macrophage activation). Blocking Lingo-1 (Ji et al., 2006; Lv et al., 2010), as well as 
the downstream effector molecules RhoA (Dergham et al., 2002; Fournier et al., 2003; 
Lord-Fontaine et al., 2008) and Rock (Duffy et al., 2009; Fournier et al., 2003) have 
also been shown to enhance outgrowth. There are several factors that influence 
neuronal outgrowth and an interesting example comes from the studies of Nogo knock-
out animals; three different labs created three different Nogo knock-out mice that 
showed marked discrepancies in their regenerative phenotype (Kim et al., 2003; 
Simonen et al., 2003; Zheng et al., 2003). Later studies have confirmed that effects 
such as age, strain and type of lesion affects the regenerative response (Cafferty et al., 
2007a; Cafferty et al., 2007b; Dimou et al., 2006). When OMgp and MAG were also 
knocked out in a Nogo-A null background that still retains a small N-terminal part of 
Nogo-A, significant regeneration of corticospinal tract fibers was seen in a mouse 
model of spinal cord injury (Cafferty et al., 2010). In contrast, in mice with complete 
knock-out of Nogo-A, no regeneration of the CST was noted (Lee et al., 2010). Acute 
blocking of Nogo-A has been shown in several studies to be beneficial for outgrowth 
(reviewed in (Akbik et al., 2012; Gonzenbach and Schwab, 2008; Pernet and Schwab, 
2012; Xie and Zheng, 2008). 
 
Beneficial effects of blocking the nerve growth inhibitory systems have also been seen 
in stroke models (Cheatwood et al., 2008; Lee et al., 2004). Using viral mediated RNAi 
against NgR1 it was shown that the amount of contralateral fibers to the red nucleus 
and striatum increased after NgR1 silencing (Wang et al., 2010). In a second study 
(Shehadah et al., 2010), a combinatorial treatment of rats exposed to middle cerebral 
artery occlusion showed an increase in recovery and the treatment also resulted in a 
significant reduction in NgR1 expression. This fits well with the fact that outgrowth 
after injury is enhanced in slice culture after Nogo-A (Craveiro et al., 2008) or NgR1 
inhibition (Mingorance et al., 2006). Another Nogo receptor, PirB, has been shown to 
be able to bind MAG, OMgp and Nogo and induce growth cone collapse in vitro 
(Atwal et al., 2008) as well as increase plasticity in the visual cortex (Syken et al., 
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2006). However, lack of PirB has not led to improvements of regeneration following 
traumatic brain injury (Omoto et al., 2010) or spinal cord injury (Nakamura et al., 
2011).  
 
REGULATION OF MYELIN INHIBITORS  
There is substantial evidence to support the notion that neurons are highly plastic in the 
intact brain and that sensory inputs can cause structural synaptic plasticity (Bhatt et al., 
2009; Holtmaat and Svoboda, 2009; Yang et al., 2009). It is therefore likely that the 
normal inhibition of neurite growth in the CNS is modulated by neuronal activity to 
allow for local plasticity. In fact, forced neuronal activation by Kainic acid (Josephson 
et al., 2003; Karlen et al., 2009; Mingorance et al., 2004; Wills et al., 2012)  results in a 
rapid downregulation of NgR1 in both hippocampus and the cerebral cortex (Josephson 
et al., 2003). In the same study, NgR1 was also shown to be downregulated in the brain 
in rats given access to running wheels (an activity that has been shown to increase 
synaptic plasticity). This downregulation could allow for increased plasticity at specific 
positions during a limited time window. Support of this hypothesis came when it was 
shown that NgR1 was downregulated in the somatosensory cortex in rats subjected to a 
thoracic spinal cord injury (Endo et al., 2007). The downregulation of NgR1 was 
specifically seen in those parts of the somatosensory cortex that responded to 
stimulation of the hind- and forelimbs. Using fMRI it was shown that the area that used 
to be activated by the forelimbs expanded into the area that used to receive input from 
the hind limbs; hence the downregulation of NgR1 was specific to the areas that were 
undergoing plastic changes. NgR1 is also downregulated at 7-15 days following 
hippocampal lesions (Mingorance et al., 2004). Of note, there was a small upregulation 
24 h after the lesion. To conclude, NgR1 is downregulated in association with increases 
in neuronal activity or plastic changes. Following middle cerebral artery occlusion 
NgR1 expression was shown to increase (Wang et al., 2010). However, when rats with 
middle cerebral artery occlusion received a combinatorial treatment that resulted in 
functional improvement, NgR1 levels were decreased suggesting that lower than 
normal levels of NgR1 expression can be beneficial for neuronal outgrowth/repair 
(Shehadah et al., 2010). While Nogo-A levels generally appear to be more stable 
increases have been noted in a rat stroke model in cortical areas after 28 hours 
(Cheatwood et al., 2008). Interestingly, there was a transient downregulation during the 
first 1-14 days after the stroke (Cheatwood et al., 2008). 
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NOGO-RECEPTORS AS REGULATORS OF SYNAPTIC 
PLASTICITY IN THE INTACT CNS 
Recently, there has been an increased interest in the possible roles of MAIs in the 
uninjured nervous system. Given that NgR1 is expressed selectively by neurons, and 
that Nogo is also expressed by a set of neurons, one focus of interest has become gray 
matter and structural synaptic plasticity.  
 
MYELIN ASSOCIATED INHIBITORS IN EXPERIENCE-DEPENDENT 
PLASTICITY 
The first conclusive evidence that the Nogo system is involved as a regulator of plastic 
changes came in studies on plasticity in the visual cortex after monocular deprivation. It 
has long been know that by closing the contralateral eye, the visual cortex will 
increasingly start to respond to information from the ipsilateral eye (Hofer et al., 2006). 
In a paper from 2005 McGee and colleagues found that plasticity in the visual cortex 
remained high after monocular deprivation past the critical period for such plasticity 
(that normally ends around day 32), in mice that lacked NgR1 (NgR1-/-) (McGee et al., 
2005). In fact even NgR1-/-mice that were 4 months old exhibited significant plasticity 
in their visual cortex. Furthermore, when Nogo-A/B was knocked out plasticity was 
increased similarly as seen in mice lacking NgR1, suggesting that Nogo signaling 
through NgR1 could be a mechanism by which plasticity is normally suppressed 
following closure of the critical period. Nogo-A, OMgp and MAG can also bind to a 
second receptor called PirB (Atwal et al., 2008) and deletion of this receptor has also 
been shown to result in increased plasticity in the visual cortex following monocular 
deprivation (Syken et al., 2006). Furthermore, rearing mice in the dark has been shown 
to delay the maturation of GABAergic neurons as well as the deposition of CSPG into 
perineuronal nets and affect the monocular response (Pizzorusso et al., 2002). Recently 
it has also been shown that NgR1 as well as NgR3 works as receptors for CSPGs 
suggesting that NgR1 might also play a role in the CSPG induced response as well 
(Dickendesher et al., 2012).  
 
STRUCTURAL PLASTICITY 
The first evidence supporting a role for the Nogo-system in plastic responses in the 
uninjured CNS came when it was shown that addition of IN-1 antibody to uninjured 
cerebella resulted in increased axonal sprouting already after two days, an effect that 
disappeared after one month (Buffo et al., 2000). When organotypic hippocampal 
cultures were treated with an anti-Nogo antibody it resulted in significant changes in 
dendritic structures as measured by Scholl analysis. When NgR1 or Nogo-A were 
inhibited with a blocking antibody there was a profound effect dendritic structure and 
spine types, while changes after Nogo-A deletion were smaller (Zagrebelsky et al., 
2010). Nogo-A knock-out mice have also been shown to have increased growth cone 
motility and this appears to be dependent on changes in RhoA activation (Montani et 
al., 2009). It has recently been shown in both cell and tissue culture that loss of NgR1, 
NgR2 or NgR3 independently will result in an increase in spine density (Wills et al., 
2012). Furthermore, overexpression of NgR1 resulted in decreased spine density in 
vitro. In vivo, a single knock-out of any of the three NgR genes did not result in an 
increase in spine density. However, when all three Nogo-receptors were knocked out, a 
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significant increase in spine density was seen in vivo (Wills et al., 2012). It has also 
been shown that this effect appears to be mediated by the co-receptor TROY and the 
downstream regulator RhoA. It was also confirmed that NgR1 is regulated by neuronal 
activity as previously demonstrated (Josephson et al., 2003) but also that NgR2, NgR3 
and TROY are regulated by neuronal activity.  
 
ELECTROPHYSIOLOGICAL PLASTICITY 
Changes in electrophysiological activity such as LTP and LTD have been linked to 
changes in synaptic structure (Saneyoshi et al., 2010). Addition of Nogo-66 or OMgp 
to hippocampal slices result in reduced LTP in a NgR1 dependent manner (Raiker et 
al., 2010) and blocking Nogo-A or NgR1 using blocking antibodies increase LTP 
(Delekate et al., 2011). While NgR1-/- mice do not show any impairment in LTP 
induction (Lee et al., 2008; Raiker et al., 2010) they do exhibit impairment of LTD. 
When NgR1 is instead overexpressed, the formation, length and de-potentiation of LTP 
is similar to that seen in control mice (Karlen et al., 2009), even though such 
overexpression severely impairs the ability to from lasting memories (see results 
below).  
 
MYELIN INHIBITORS IN DISEASE  
The Nogo-system has been implicated in both neurodegenerative and neuropsychiatric 
diseases. For instance, it has been shown that Reticulon members (He et al., 2004), one 
of them being Nogo-A, can bind to and modulate the activity of BACE1, a key 
molecule in the formation of Aβ (Hardy and Selkoe, 2002). Nogo knockout mice that 
overexpressed APP showed less impairment in the Morris water maze compared to 
control mice, without affecting plaque load (Masliah et al., 2010). The expression of 
synaptic proteins was however normalized, and a possible conclusion is that loss of 
Nogo-A can partly rescue the memory impairment in these mice by increasing 
compensatory plasticity. Nogo-B expression has been shown to increase in aged and 
Aβ treated rats, while Nogo-A expression was not changed. Nogo-B expression was 
correlated with increased activity of microglia and impairments of LTP induction 
(Murphy et al., 2011). Of note, Nogo-A expression has been shown to increase in a 
group of aged rats with cognitive impairment compared to age matched controls and 
the Nogo-A levels had an inverse correlation with performance (VanGuilder et al., 
2011).  
 
Nogo receptors have been implicated in modulating plaque formation in a mouse model 
of Alzheimer’s disease (APPswe/PSEN1). Park and colleagues showed that NgR1 can 
bind to APP and Aβ and that NgR1 overexpression in neuroblastoma cells decreased 
Aβ production (Park et al., 2006a). When NgR1-/- mice were crossed with 
APPswe/PSEN1 mice, NgR1-/-/APPswe/PSEN1 animals had a higher plaque load than 
NgR1+/-/APPswe/PSEN1 mice, suggesting that NgR1 can influence plaque formation. 
In a follow up study, subcutaneously delivered soluble NgR1 decreased plaque loads 
(possibly by working as a peripheral sink for Aβ) and attenuate the age related decline 
in cognitive function seen in APPswe/PSEN mice with control treatment (Park et al., 
2006b). There are also reports to suggest that while the neuronal density in Alzheimer 
patients decrease, the density of NgR1 expressing neurons stays rather stable in the 
dentate gyrus (Zhu et al., 2007), suggesting that NgR1 might have some protective role 
or that neurons that do not normally express NgR1, induce expression in Alzheimer 
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patients. Zhou and colleagues (Zhou et al., 2011) confirmed that NgR1 can bind to APP 
but unlike the study by Park and colleagues (Park et al., 2006a) they found an 
interaction between APP and all NgRs, but no interaction between NgRs and Aβ. Zhou 
and colleagues also found that overexpression of NgR2 (and to a lesser extent NgR1 
and NgR3) increased the formation of Aβ and mice lacking NgR2 had reduced 
depositions of Aβ.  
 
The Nogo system has also been linked to schizophrenia, and mutations in NgR1 (that 
affect Nogo binding) have been found in patients with schizophrenia. NgR1-/- mice 
show some phenotypes akin to schizophrenia (Budel et al., 2008). Mice lacking Nogo-
A were also found to exhibit phenotypes common in schizophrenia (Willi et al., 2009; 
Willi et al., 2010).   
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MEMORY 
The brain has the capability of storing our experiences as long-term memories that in 
some instances can be recalled for the rest of our lifetime. The form in which these 
memories are stored has been difficult to elucidate. However, there is now a growing 
agreement that long-term memory formation involves structural changes in the 
neuropil. The formation of new contacts and the elimination of old contacts cause an 
alteration of the synaptic network which in turn carries the new memory.  
 
As plastic changes within telencephalon are believed to be the anatomical foundations 
of memories, it is interesting that the CNS of mammals is highly inhibitory to neuronal 
outgrowth. The aim of this thesis was to investigate how some of these inhibitors 
(mainly the NgR1) are regulated by neuronal activity and to see if they can influence 
the formation of long-term memories. 
 
Memory does not appear to exist in a single functional system that handles all types of 
information that is intended to be retained. Current models of memory instead describe 
a variety of different memory systems that can work, to some extent, independently so 
that damage to one system will not necessarily impair function in other systems. These 
memory systems do not only differ in the type of information that they handle but they 
also appear to utilize different regions of the brain for their function.  
 
WORKING MEMORY 
The terms short term memory and working memory are sometimes used as synonyms 
and sometimes with distinction, generally that working memory involves conscious 
manipulation of information while short term memory typically refers to storing it 
(Baddeley, 2003). In this thesis they will both be described as “working memory” and 
refer to information that can be held in mind simultaneously without the involvement of 
long-term memory. Some studies suggest that when working memory is stretched to its 
limit it might also engage the medial temporal lobe/hippocampus (Jeneson and Squire, 
2012; Squire and Wixted, 2011). 
 
DESCRIPTIVE MEMORY 
Descriptive memories are the foundation of what is normally considered our long-term 
memory and are divided into semantic memories (facts) and episodic memories 
(experiences). These memories can either be retained for a brief interval (for example, 
when cramming for an exam) or can be long-term as (hopefully) remembering your 
door/pin code. The exact relation between semantic and episodic memory is not 
established but it has been postulated that semantic memory forms a foundation that 
higher order memories (episodic) can be built upon (Eustache and Desgranges, 2008). 
There are suggestions that semantic and episodic memories uses somewhat different 
brain systems (Vargha-Khadem et al., 1997), while other studies support the claim that 
hippocampus is essential for both types of memories (Manns et al., 2003a; Manns et al., 
2003b).  
 
Long-term memory refers to information that can be stored for a prolonged period of 
time in the brain. A key to our understanding of which brain structures that are needed 
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for the formation of long term memories were the observations of a neurosurgical 
patient (H.M.) who in 1953 (Scoville and Milner, 1957; Squire, 2009) had surgery to 
remove parts of his medial temporal lobes bilaterally, to address irretractable epileptic 
seizures. What was not known at the time, but became apparent after, is that the medial 
temporal lobes are essential for the formation of new long-term memories. H.M. was 
not impaired on IQ-tests following the surgery (in fact his performance improved) but 
his ability to form new descriptive memories was severely impaired. The lesion in 
H.M. was far too large to specifically identify the important regions but following the 
discovery of the importance of the medial temporal lobe in memory formation, several 
other reports both in patients (Manns et al., 2003a; Manns et al., 2003b; Rempel-
Clower et al., 1996; Zola-Morgan et al., 1986) and in animals (Squire and Zola-
Morgan, 1991; Zola-Morgan et al., 1986; Zola-Morgan et al., 1994) have clarified the 
structures involved in long term memory formation. The general picture that has 
emerged is that while damage to the hippocampus (for instance only the CA1 area) was 
sufficient to result in memory impairment it is not enough to cause an impairment that 
is similar in extent to that seen in H.M. Instead it appears that other structures such as 
the entorhinal, perirhinal, and parahippocampal cortices are also involved in memory 
processing and together they make up a large part of the parahippocampal gyrus. MRI 
studies of patients that exhibit memory impairments after anoxic experiences have 
repeatedly shown reduction in hippocampal volume of around 40% (Cipolotti et al., 
2001; Isaacs et al., 2003; Shrager et al., 2008; Squire et al., 1990). Regions outside of 
the telencephalon, most notably in the diencephalon, are also important for memory 
functions and several studies have implicated nuclei in thalamus (especially the medial 
dorsal nucleus) in memory impairments (Gold and Squire, 2006; Harding et al., 2000; 
Mayes et al., 1988; Squire et al., 1989).  
 
A very important distinction is that while the medial temporal lobes are required for the 
formation of long-term descriptive memories, it does not appear to be the storage site 
for these memories. Instead it is believed that long-term memories reside in neocortex 
(Danker and Anderson, 2010) close to the regions that originally interpreted the 
information and that have been shown to be re-activated during retrieval (Nyberg et al., 
2000). Hence damage to the region of the brain that process color would impair 
retrieval of “colorful memories”, something that has also been seen in a patient (Sacks, 
1995). The amnesia seen after medial temporal lobe lesions is generally antereograde, 
but retrograde amnesia of a period ranging from a few years up to a decade before 
medial temporal lobe damage can be seen depending on the extent of the lesion (Bayley 
et al., 2006; Bright et al., 2006; Manns et al., 2003b). In this thesis memories that last 
for longer than three weeks will be defined as lasting memories and as will be 
described in the results section these type of lasting memories are affected by 
overexpression of NgR1. 
 
NON-DECLARATIVE MEMORY 
These are memories that are stored in the brain and influence our behavior but unlike 
declarative memories, we are not aware of how the information contained in non-
declarative memories is stored. For example we know how to ride a bike but cannot 
explain how we specifically learned to master it. 
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Perceptual memories 
Perceptual memories refers to information that is perceived and that can later affect our 
behavior but without entering our conscious mind. For instance when people are shown 
words in one context such as counting the number of letters in each word the brain will 
unconsciously be primed for these words. When subjects are later shown only the first 
few letters of these words and are asked to fill in the last part, they use the words shown 
earlier at a higher frequency then other words starting with the same stem, even though 
they have no conscious recollection of previously seeing the words (Tulving, 1982). 
Patients with severe MTL lesions have been shown to have normal perceptual 
memories but these may not be as long lasting as in controls (Squire et al., 1987).  
 
Procedural memories 
Procedural memory is generally considered distinct from other types of memories 
discussed above, and has received substantial attention as a system underlying many of 
our acquired motor skills. For instance while H.M. was severely impaired with regard 
to descriptive memories, his performance was comparable to controls in learning the 
mirror drawing test. Using a group of amnesic patients it was shown that they could 
learn to read mirrored words as well as controls (Cohen and Squire, 1980). Amnesic 
patients when confronted with tasks that cannot be learned, (outcome is probabilistic 
and relies on “gut feeling”), perform equally well as controls (Knowlton et al., 1996). 
Amnesic patients could learn an eight-pair discrimination task using habit memory, but 
instead of the 80 trials that the controls required, amnesic patients required > 1000 trials 
and were not aware of the fact that they had practiced the test (Bayley et al., 2005). 
Rodents with hippocampal lesions can still learn a version of the Morris water maze 
when the starting location is held constant (always same path to platform) but are 
deficient when the start location varies (require the use of external cues to locate the 
platform. Procedural memories appear to require both striatum and cerebellum and 
patients with Parkinson’s disease show impairments in tests involving procedural 
memory (Knowlton et al., 1996). 
 
SYNAPTIC PLASTICITY 
For more than a century it has been believed that both spines and the structure of 
dendrites are important for memory storage (Garcia-Lopez et al., 2007; Shepherd and 
Erulkar, 1997). Raisman provided convincing evidence for synaptic alterations in the 
brain at the EM level by deafferentation studies in the septal nucleus (Raisman, 1969) 
and a similar occurrence of denervation-induced alterations in the hippocampal 
formation was later seen (Cotman et al., 1973). It has also been shown that spines are 
highly dynamic structures. For instance, a synapse loss of around 50% is seen during 
the postnatal period (Huttenlocher, 1979; Rakic et al., 1986; Rakic et al., 1994). After 
this major change, the synaptic densities remain rather stable through to adulthood until 
a small decline can be seen in aged individuals (Duan et al., 2003; Terry et al., 1991). If 
spines are indeed part of the neuronal substrate for memory, it would be necessary for 
spines (at least some of them) to also be highly stable. While there are some 
contradictory results regarding spine stability, the overall picture suggests that there are 
indeed spines that are stable for very long time periods and that the difference that was 
initially seen was due to different methods and did not reflect differences in factual 
spine dynamics (Holtmaat et al., 2005; Mizrahi et al., 2004; Pan and Gan, 2008; Xu et 
al., 2007). If spines are indeed important for the formation of memories then they 
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should change in response to stimuli. When LTP is induced in brain slices there is also 
an increase in dendritic growth and spine formation (Engert and Bonhoeffer, 1999; 
Maletic-Savatic et al., 1999; Toni et al., 1999; Zhou et al., 2004) while LTD induction 
reduces spine numbers and results in spine shrinkage (Nagerl et al., 2004; Zhou et al., 
2004). Furthermore, increases in spine density have been reported after environmental 
enrichment, rearing training and long term sensory stimulation (Greenough et al., 1985; 
Knott et al., 2002; Kolb et al., 2008; Moser et al., 1994). In a highly influential paper it 
was shown that formation of new spines correlated with improvements in the 
accelerating Rotarod and that some of the newly formed spines were highly stable 
(months) (Yang et al., 2009). Spine density can also be increased by the administration 
of drugs of abuse; interestingly while both psychostimulants and opiates show very 
similar initial behavioral responses the changes in neuronal structures are opposite 
(Luscher and Malenka, 2011; Russo et al., 2010). Thus psychostimulants increase spine 
density while opiates have the opposite effect. There are several proteins that influence 
spine dynamics (Bhatt et al., 2009) but of specific interest for this thesis is the notion 
that RhoA is highly involved (Linseman and Loucks, 2008; Schubert and Dotti, 2007). 
 
PLASTICITY IN HUMANS 
While the possibilities to study spine dynamics in animal models has increased 
tremendously by the development of in vivo two-photon microscopy, the possibilities to 
study spine changes and dynamics in humans is still challenging at best. Most studies 
have focused on indirect methods such as change in size of brain areas. One of the first 
studies to implicate changes in brain structure with activity in humans was the a study 
showing that taxi drivers in London had larger posterior hippocampi (but smaller 
anterior hippocampi) than control individuals (Maguire et al., 2000). Following this 
study, several studies have shown changes in brain structure as the result of a plethora 
of circumstances; for instance in students studying for an extensive medical exam both 
the hippocampus and part of the parietal lobe increased in size (Draganski et al., 2006). 
Many other examples exist and include several different types of experiences (reviewed 
in (Fields, 2011). However, most of these studies have used MRI or similar techniques 
so it is not possible to know the exact substrate of this plasticity. For instance, it is 
appealing to assume that training would result in an increase in dendritic arborization 
and an increase in spine density but other explanations such as increased 
vascularization cannot be ruled out.  
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AIMS 
 
 
 
To investigate the distribution and regulation of the Nogo-receptors and the NgR1 
inhibitor LOTUS 
 
 
To analyze the effect of NgR1 overexpression on lasting memories 
 
 
 To determine if NgR1 overexpression in forebrain neurons affects plaque deposition or 
cognition in a mouse model of Alzheimer’s disease 
 
 
To examine if NgR1 overexpression affects the formation and stability of a behavioral 
sensitization induced by psychostimulants 
 
 
To analyze if NgR1 overexpression affects spine dynamics	
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MATERIALS AND METHODS 
 
ANIMALS 
Experiments in this thesis were approved by the Stockholm Animal Ethics committee. 
 
MemoFlex mice 
NgR1 overexpressing mice (MemoFlex) were created by cloning a 1.4 kb fragment of 
mouse NgR1 into the HindIII-XbaI site of pTRE2 mice (BD Biosciences Clontech). 
The resulting plasmid was purified and microinjected into pronuclei of fertilized mouse 
eggs from C57BL/6 mice (MouseCamp, Karolinska Institutet). The resulting mice, 
pTRE-NgR1 were crossbred with mice carrying a tTA transgene under the control of 
the CamKII promoter (Jackson Laboratories) to create MemoFlex mice. The 
overexpression of NgR1 can be turned off by adding doxycycline to the drinking water 
(100 mg /l in paper I and 200 mg/l in paper III). 
 
NgR1 knockout mice 
The NgR1 knockout mice used in study III were a kind gift from Dr. Marc Tessier-
Lavigne (Genentech,USA) and have been described previously (Zheng et al., 2005).  
 
Housing 
Mice were group housed separated based on sex (weaned at 3 weeks of age) in cages 
with access to food and water ad libitum. Mice were kept on a 12/12 hour light/dark 
cycle; lights were on between 06:00 and 18:00. The temperature was kept at 22-23°C 
with a relative humidity of 60 %. In the cages, mice had access to a small paper house 
and tissue paper as “enrichment”.  
 
LOCOMOTOR, BALANCE AND COORDINATION TESTS 
 
Rotarod 
To assess if overexpression of NgR1 would result in impairment of motor function we 
analyzed the performance of mice in a Rotarod test. Mice are put on a horizontal rod 
that can change rotating speed and the time they stay on the Rotarod is measured. 
During the first day mice were exposed to three training sessions. In the first, mice were 
habituated with a stationary rod and in the two subsequent trials the rod rotated at a 
fixed speed (4 rpm).  The trials were 180 s with a 60 s inter-trial rest period. On the 
second day the rod was set to accelerate from 4-40 rpm and each mouse was trained 
twice for 180 s (60 between trials). On the third day (test day) two trials were 
administered with an accelerating rod (4-40 rpm) with a trial length of 300 s (60 s 
between trials). The latency to fall (or rotate off the top of the rod) was measured by the 
Rotarod timer and the average for the two trials was used as a measure of locomotor 
proficiency for the mouse.  
 
Locomotion and Open Field 
We used a multi-cage automated system that uses infrared beams to measure locomotor 
activity and explorative behavior (AccuScan VersaMax, Accuscan Instruments) to 
assess the amount of basal locomotor activity in MemoFlex mice. This apparatus 
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consists of eight transparent Plexiglas chambers (42 * 42 *30 cm) connected to a 
computer system that measures the number of beam breaks. These are then converted 
to horizontal and rearing activity and summed for 5 min bins for 60 min total.   
 
Elevated Plus-Maze 
To assess anxiety associated behavior the elevated plus maze system was used. This 
maze consists of 4 arms (30 cm long 5 cm wide); two of these are closed with gray 
walls and two of the arms are open (lacking walls). The maze was elevated 60 cm from 
the ground and the amount of time and entries to the closed and open arms are recorded 
using a camera-based system (Ethovision, Noldus).  
 
Running Wheel 
Mice that are given free access to running wheel will gradually increase the distance 
they run in the wheels. MemoFlex mice and control mice were given free access to 
running wheels. During the experiment mice were single-housed in cages (22*16*14 
cm) with running wheels (r=12.4 cm; one revolution = 39 cm) for 5 weeks and the 
running activity was measured continuously. During the experiment the animals had 
free access to both food and water.  
 
MEMORY TESTS 
 
Morris water maze 
Morris water Maze (MWM) (Morris, 1984) is one of the most widely used tests for 
testing visuospatial memory (Vorhees and Williams, 2006) in mice and has been shown 
to rely heavily on the function of the hippocampus (D'Hooge and De Deyn, 2001; 
Sharma et al., 2010). 
 
We used the Morris water maze in papers I and II to assess the ability of our different 
mice strains to form spatial hippocampal dependent memories.  In our setup of the 
MWM we use a circular tank (180 cm in diameter) with a hidden platform (10 or 15 
cm) in diameter. Surrounding the tank several external cues were placed to assist the 
mice in “triangulating” the location of the platform. North in the tank was defined as 
the pool position furthest from the experimenter and south as the closest, west is to the 
left of the experimenter and east to the right. These positions were used as starting 
positions for the mice. Mice were trained for 4 trials per day during 7 days (28 trials in 
total). In each trial the mice were semi-randomly (never the same starting location 
twice in one day) put into one of the four starting points (north, east, south and west). 
There was at least 30 minutes between two trials for the individual mice. During the 
learning phase the platform remained in a constant position in one of the four quadrants 
of the water maze. We used the Morris water maze to assess hippocampal dependent 
memory. To verify that the learning was indeed hippocampal dependent and not due to 
other strategies used by the mice, such as swimming at a constant distance from the 
wall, we used probe trials (without platform) at various time-points (after the learning 
phase or during follow-up tests of long lasting memory) to assess if mice spend more 
time in the quadrant that used to contain the platform compared to the 3 other 
quadrants. After putting mice into the tank the experimenter moves to an adjacent room 
and the performance of the mice is recorded using a video system and several 
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parameters (latency, distance, swim speed, thigmotaxis etc) can be analyzed using a 
computer program (Water Maze Software). To assess how stable the learning of the 
platform location had become in our mice we retested them in the MWM after a 
prolonged delay (39-60 days).  
 
Radial Arm Water maze 
In paper II mice were also tested in a radial arm water maze (RAWM) that compared to 
the open pool in MWM instead consists of a small open center zone (40 cm in 
diameter) from where 6 arms (30 cm long and 19 cm wide) emanate. In one of the 6 
arms a hidden platform was placed and the other 5 arms were used as starting locations. 
The mice were trained in the RAWM for 4 days with 4 trials per day. During each trial 
mice were semi-randomly (never same arm twice) put into one of the empty (no 
platform) arms and during 60 s the number of entries into arms that did not contain a 
platform was recorded. The location of the platform was held constant during the 
learning phase but changed between experiments (some mice were tested in the maze 
more than once).  
 
Passive avoidance 
Memories that involve aversive events (fear conditioning) are generally thought to rely 
heavily on the function of amygdala. (LeDoux, 2007; Sigurdsson et al., 2007). One way 
to assess fear memory is to use a contextual system where in a two compartment box 
one room is associated with fear while the other room is not. The preference for the 
non-associated box can be used to assess the strength of the fear memory.  
 
We used two different systems (Ugo Basile and TSE Systems) that differed somewhat 
in how movement of mice was measured and in the size of the boxes to test passive 
avoidance (paper I). The learning phase for these tests consists of a single exposure; 
mice were put into the bright side of a two compartment box with one illuminated 
(bright) side and one dark side. The two sides of the box are separated by a door that is 
closed when the mice is put into the box. After 60 s of exploration the door will open 
and mice will have access to the dark compartment as well. When the mouse enters the 
dark compartment the door will close and a single foot shock will be administrated (0.3 
mA, 2 s, via a metal grid floor). Thereafter, the mouse was left in the dark compartment 
for 30 s after the shock before being removed (a maximal time of 300 s is set and if 
mice did not enter they were removed from the study). To investigate the retention of 
these memories, mice were re-exposed to the apparatus after 1 and 7 days as well as 
after 4 weeks. During these retention tests the door between the compartments was left 
open during the entire trial time (300 s) and no shock was administered and the time 
before mice entered the dark compartment was recorded (mice that did not enter the 
dark compartment were assigned the time 300 s).  
 
Drug induced sensitization 
It is well known that mice that are given psychostimulants will show an increase in 
locomotion with repeated administration, even if the dose is held constant. In paper III 
we exposed both NgR1 overexpressing mice and NgR1 knockout mice (NgR1-/-) to a 
sensitization paradigm. 
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To measure drug induced locomotor activity, mice were put into AccuScan boxes as 
previously described. This enabled us to closely measure locomotor activity and also 
provides a new environment for the sensitization, something that has been shown to 
enhance the sensitization response (Badiani et al., 1995). We used a 9 day sensitization 
paradigm, during the first two days mice get saline injections and for the last 7 days 
they will receive injections of D-amphetamine 2mg/kg (Lipomed, Arlesheim, 
Switzerland), both I.P. All trials were 90 min long and after the experiment mice were 
returned to their home cages. The Accuscan boxes also recorded stereotypy behavior. 
 
CELLULAR EXPRESSION OF MRNA SPECIES 
 
Oligonucleotide probes 
One way to measure mRNA levels is to use quantitative in situ hybridization (ISH). It 
has been shown that expression levels measured by ISH and quantitative PCR correlate 
strongly (Broide et al., 2004), confirming accuracy of quantitative ISH. In papers I and 
IV ISH using oligonucleotide probes of ~50 bp were used to analyze the expression of 
mRNAs of interest. To ensure that the probes were specific they were first aligned to all 
publicly known sequences using UCSC genome browser (http://genome.ucsc.edu/) and 
folding energy was assed using Mfold (Version 3.2) (Mathews et al., 1999; Zuker, 
2003). Two or more oligonucleotides, targeting different parts of a given mRNA of 
interest were created and the expression of both were compared before one was chosen 
for the experiments (expression patterns were identical but some probes generated 
stronger signals and were chosen for subsequent experiments), expression patterns were 
also compared to previously published data when available. The following 
oligonucleotides were used: 
 
 Paper I Nogo-A: (5 -GCT CTG GAG CTG TCC TTC ACA GGT TCT GGG GTA 
CTG GGG AAA GAA GCA-3 ), NgR1: (5 –AGT GCA GCC ACA GGA TGG TGA 
GTA TCC GGC ATG ACT GGA AGC TGG C-3 ), transgene-specific NgR1: (5 -
GGA GGC TGG ATC GGT CCC GGT GTC TTC TAT GGA GGT CAA AAC AGC 
GTC-3 ), endogenous-specific NgR1: (5 -TTC GGG GTC GAG CGG GGC GCG TCG 
GGC ACT GGA AGC GGC TTC GGG GCG-3 ), Lingo-1: (5 -TCC AAG ACC TTG 
AGT CGG TAC AGC CTC TTG AAG GAG TAG TCC CGG ATG GC-3 ), Troy: (5 -
TTT ATT CCT GCT ACT CGC CAG TGC TGT GCT CCA GAC TCA CGC TTT 
CCG-3 ), p75 (5 –GGC CAC AAG GCC CAC GAC CAC AGC AGC CAG GAT 
GGA GCA ATA GAC AGG-3 ) and BDNF (5 -CTC CAG AGT CCC ATG GGT 
CCG CAC ACC TGG GTA GGC CAA GCT GCC TTG-3 ) 
 
Paper IV: NgR1: (5-GTG CAG CCA CAG GAT AGT GAG ATT TCG GCA TGA 
CTG GAA GCT CGC AGC TTC GGG GCG-), NgR2: (5-AGG GCG CTC AGT CCA 
CAC TTA TAG AGG TAG AGG GCG TGA AGC TTC-3), NgR3: (5-AAG GAC 
AGC GGC ACT GAG GAG AAG TTG TTG GCC TGG CAG CTC ACG GT-3)”, 
LOTUS: (5-ACA GAC AGT GGC TGA GCC ATG GAC TCT CCA TGT GAC AAG 
ATG AGA TAA AGC A-3). 
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In situ hybridization 
In situ hybridization was performed based on the procedure developed by Dagerlind 
and colleagues (Dagerlind et al., 1992). Probes were labeled with 33P at the 3’ end using 
terminal deoxynucleotidyl transferase (TdT) (Amersham Biosciences, 
Buckinghamshire, UK) and purified using ProbeQuant G50-Micro columns 
(Amersham Biosciences). Before processing, cryosections were air-dried for 3-5 h after 
which they were hybridized over night at 42°C in a humidified chamber; labeled 
Oligonucleotides were added to the hybridization mixture and covered with Parafilm 
(Parafilm M, VWR international). After overnight incubation slides were washed 5 
times in 1X SSC buffer (60°C) for a total time of an hour, cooled to room temperature 
and dehydrated using rapid submersion in increasing concentrations of ethanol (50%, 
95%, 99.5%) and air dried.  
 
Visualisation of probe radioactivity 
When the ISH slides have dried they are placed overnight with phosphoimaging plates 
to ensure quality and strength of labeling and to determine the exposure time needed for 
film autoradiography (Fujix BAS-3000; Fuji Photo Film Co, Tokyo, Japan). When an 
appropriate time exposure time has been established, slides were placed on 
autoradiographic films (Biomax; Eastman Kodak Co, Rochester, NY, USA), a 14C 
standard was also included and the slides were left on film for between 2 days and 4 
weeks, depending on the strength of the probe. The films were developed and scanned 
(Epson perfection pro V750, Epson, Nagano, Japan) and the expression in defined areas 
was quantified using appropriate software (ImageJ (V1.32 and 1.44p), 
http://rsb.info.nih.gov/ij/). Measured expression levels are then converted to nCi/g 
(Paper I) or expressed as percent of controls (Paper IV). 
 
Western blot 
For paper I, adult mouse tissues (hippocampus, olfactory bulb, spinal cord, cortex and 
striatum) were dissected and frozen using liquid nitrogen and kept in a -80°C freezer 
until used. Tissues were sonicated in 1% sodium dodecyl sulfate and boiled for 10 min.  
Aliquots of the homogenate were used for protein content determination using the 
bicinchoninic acid protein assay method (Pierce). Protein (60 µg) from each sample 
were loaded onto a 10% polyacrylamide gel and separated by SDS-polyacrylamide gel 
electrophoresis after which the proteins were transferred to polyvinylidine difluoride 
membranes (Amersham Pharmacia Biotech). Membranes were next immunoblotted 
using a Goat anti-NgR1 antibody (R&D Systems). Anti-body binding was revealed by 
the secondary anti-goat IgG antibody (Rockland) and the Odyssey System 
immunoblotting detection system.  
 
In a second experiment, NgR1 protein expression was analyzed after adding 
doxycycline. Fresh frozen mouse tissues were lysed and sonicated in 0.5% Triton X-
100, 3% SDS, 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 1 mM EDTA containing 
protease inhibitor mixture (Sigma), NaF, and phosphatase inhibitor cocktails 1 and 2 
(Sigma).  The samples were added to SDS/PAGE (NuPage 4–12% Bis-Tris Gels, 
Invitrogen) followed by immunoblotting. Membranes were incubated with primary 
antibodies against NgR1 (R&D Systems), GAPDH (Abcam), and N-Cadherin (Novus 
Biological) washed and then probed with a secondary antibody (Alexa-680, Invitrogen 
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or IRDye-800, Licor). The membranes were later scanned using an infrared scanner 
(Odyssey, Licor). 
 
Membrane fractionation 
Fresh frozen mouse tissues were homogenized using a Dounce homogenizer in 
hypotonic buffer (10 mM NaHCO3 with protease inhibitor and phosphatase inhibitors 
cocktails). After 10-min incubation on ice, nuclei and cell debris were removed by 
centrifugation at 1 200 * g for 10 min. The resulting supernatant was removed and 
centrifuged again, this time at 21 600 * g for 30 min in a Beckman L7 ultracentrifuge to 
remove the internal membranes. This was followed by centrifugation at 150 000 * g for 
2 h to isolate plasma membranes. The pellet containing the plasma membrane was 
washed by resuspension in hypotonic buffer and centrifuged at 150 000 * g for 2 h and 
then solubilized in an extraction buffer containing 0.50% Triton-X-100, 50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% SDS, and protease inhibitor and 
phosphatase inhibitors cocktails. The expression level of NgR1 in the plasma 
membrane fraction was determined by SDS/PAGE (NuPage 3–8% Tris-acetate Gels, 
Invitrogen) followed by Western blotting as described above.  
 
RhoA activity assays 
For paper I, a commercially available ELISA-based RhoA activity assay (G-LISA; 
Cytoskeleton) was used to measure the relative RhoA activity of hippocampus from L1 
and control mice.  
 
Immunohistochemistry 
Mice were deeply anaesthetized with pentobarbital and a needle was inserted into the 
heart through which first 10 ml of Thyrode and then 50 ml of fixation solution (4% 
formaldehyde with 0.4% picric acid in PBS) were perfused. The brains were removed 
and immersed in the same fixative; later they were rinsed and kept in sucrose (changed 
>3 times). Brains were later cryosectioned (Microm HM 500 M, GM Inc USA, 14µm) 
and processed for immunhistochemistry.  Sections were rehydrated in PBS for 10 min 
and covered with blocking solution (PBS with 0.1% Triton-x, 5% goat serum, and 2% 
BSA) for 1 h. After blocking, primary antibodies were added to the sections in a 
solution similar to the blocking solution but lacking BSA. For paper I, Goat anti-NgR1 
(R%D systems) with an anti-goat Cy3 conjugated antibody as a secondary antibody 
was used. To label plaques in paper IV an anti Aβ-42 antibody (Cell signaling Danvers, 
MA, USA) was used together with a secondary anti-rabbit biotin conjugated antibody, 
visualized by an avidin HRP procedure (ABC-kit, Vector Laboratories Burlingame, 
CA, USA). To visualize NgR immunoreactivity, a goat anti-NgR primary antibody 
(R&D systems, MN, USA) and, as a neuronal marker, an anti-NeuN antibody 
(Millipore, MA, USA) was utilized. Signals were visualized using fluorescent 
secondary antibodies, anti-goat Alexa 488 and anti-mouse Alexa 535 (Invitrogen, NY. 
USA) were used. Fluorescent images were taking using a Zeiss LSM 510 Meta 
microscope and all other pictures were taken using Zeiss Axiophot. 
 
Plaque quantification 
To enhance the contrast of plaques compared to background, hue and saturation was 
modified using an automated script (same settings for all brain regions) and appropriate 
software (Adobe Photoshop®). The images were converted to black and white and 
plaque load (area occupied by plaques and plaque numbers determined using 
appropriate software (Imagej (v 1.44p, http://rsb.info.nih.gov/ij/). Identical settings 
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were used for all slides within a specific region. Serial sections were taken (every 10 
section) and the average of 4-5 were analyzed and the average number was assigned as 
the value for a given mouse brain. 
 
Golgi staining and spine counts 
To visualize the dendritic tree of neurons and enable analysis of spine structure we used 
the Golgi method; this method randomly and completely stains a few neurons and 
leaves the majority of cells unstained. It is then possible to count individual spines on 
the scattered stained neurons without much interference from surrounding neurons. We 
used a rapid Golgi staining kit (FD Rapid Golgi kit, MTR Scientific) according to the 
manufacturer’s protocol. Once the tissue was stained it was cryosectioned at 180 µm 
and spines were counted. For paper I we analyzed spine density on the apical dendrite 
of pyramidal neurons in cerebral cortex (at least 50 µm from the soma), for a distance 
of 10 µm. Spines were visually categorized as mushroom shaped or non-mushroom 
shaped. For paper III the same staining procedure was used but sections were 
performed using a microtome instead of a cryostat (200µm). Spines were measured on 
both distal apical dendrites on pyramidal neurons in the cingulated gyrus and on 2:nd 
and 3:rd order dendrites on medium spiny neurons in the shell of nucleus accumbens 
using dedicated software (Neurolucida, MicroBrightField  inc,  VT,  USA).  Spines were 
categorized as thin (thin and filopodia), mushroom or other.  
 
High-performance liquid chromatography  
Concentrations of monoamines (paper I) and their metabolites in brain tissue samples 
were determined by high-performance liquid chromatography (Andersson et al., 1995). 
The separations were accomplished using a reverse-phase column (Reprosil-Pur, C18-
AQ). Monoamines and metabolites were detected using an electrochemical detector 
system with a high sensitivity analytical cell and appropriate software (ESA 
Coulochem III and EZ Chrom Elite; ESA, Dalco Chromtech AB). Tissue level values 
were expressed as ng/g wet weight.  
 
Electrophysiology  
Brains were removed and immersed in cold (4 °C), oxygenated media, composition 
(mM): NaCl, 87; KCl, 2.5; MgCl2, 7; CaCl2, 0.5; NaH2PO4, 1.25; glucose, 25; sucrose 
45; and NaHCO3, 25. Transverse slices (280 m) were made using a vibrating tissue 
slicer (VT1000S, Leica Instruments), and incubated in normal media consisting of 
(mM): NaCl, 126; KCl, 3.0; MgCl2, 1.0; CaCl2, 2.4; NaH2PO4, 1.2; glucose, 11.0; and 
NaHCO3, 25, saturated with 95% O2 and 5% CO2. Individual brain slices were then 
moved to a recording chamber that was continuously perfused with normal media (3 
mL/min), and maintained at a temperature of 30–32 °C.  A blinded experimenter 
performed recordings in the CA1 region of hippocampus. Extracellular fEPSPs were 
recorded in stratum radiatum using glass micropipette electrodes filled with 3M NaCl, 
and an AC amplifier (A-M Systems Model 1800). The signals were high- (10 Hz) and 
low-pass (10 kHz) filtered, and acquired to a personal computer at 4 kHz via an A/D 
board (National Instruments PCI 6251), using appropriate software (WinLTP v0.95b, 
courtesy of Dr. William A. Anderson, University of Bristol, Bristol, U.K.). fEPSPs 
were elicited by electrical stimulation of stratum radiatum at a frequency of 0.033 Hz 
using single, 0.1-ms pulses, delivered through a bipolar electrode constructed using 
formvar insulated nichrome wire. After obtaining an input-output relationship (stimulus 
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intensity versus peak fEPSP amplitude) for each response, the stimulus intensity was 
adjusted to produce a baseline fEPSP with a peak amplitude of 0.5–1 mV (30–40% of 
the maximum response). After at least 10 min of stable baseline, LTP was induced by 
either (1) high frequency stimulation (HFS) consisting of three trains of 1-s duration at 
100 Hz, delivered at 20-s intervals; or (2) theta-burst stimulation (TBS) consisting of 10 
bursts of five pulses at 100 Hz, with a 200-ms inter-burst interval. Both HFS and TBS 
were delivered at the stimulus intensity used to elicit the baseline responses. Peak 
amplitude and slope of the initial (1–2 ms) rising phase of the fEPSP were calculated 
using the acquisition software, and changes in the synaptic response were normalized to 
the baseline period. De-potentiation was induced by delivery of 1-Hz stimulation for 
either 5 or 15 min, beginning 5 min following TBS. 
 
Kainic acid administration 
In order to investigate how neuronal activity regulates mRNA expression of selected 
genes we administered Kainic acid (30 mg/kg i.p.) to mice as a single injection to 
induce profound neuronal activity (seizures). Following injections, the mice were 
carefully monitored and seizure activity was scored using a standardized seizure 
scoring scale (Sperk et al., 1985). Only mice that received a grade IV (rearing) or V 
(falling over) seizure score were included in the subsequent analysis.  
 
Statistics 
Data are always presented as the mean value with SEM unless otherwise stated.  
Comparisons between two groups were performed using unpaired t-tests, if several 
groups were included a general linear model was used with appropriate levels (for 
example one-way ANOVA for Kainic acid experiments). For behavioral experiments a 
generalized estimating equation procedure with an autoregressive covariance matrix or 
a mixed linear model was used. To further analyze the data, appropriate post hoc tests 
(with Bonferroni corrections) were used and specific tests were chosen both based on 
the contrast of interest and the variance structure. 
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RESULTS AND DISCUSSION 
The focus of this thesis has been to study the role of the Nogo-system with a strong 
focus on NgR1 and its roles in the intact nervous system. We have also analyzed the 
regulation and expression of the two homologous Nogo-receptors, NgR2 and NgR3 as 
well as LOTUS, an NgR1 inhibitor. To investigate if NgR1 is involved in memory 
formation we created a mouse model that overexpresses NgR1 in forebrain neurons 
(using the CamKII promoter to drive expression), the MemoFlex mouse. Using this 
mouse model we have investigated how NgR1 overexpression in forebrain neurons 
(and thereby inability to down-regulate NgR1 when needed) affects the formation and 
stability of spatial memory and fear conditioning memory. We have also investigated if 
MemoFlex mice have a different response to drugs of abuse by exposing the mice to a 
sensitization paradigm. Finally, we have investigated how NgR1 overexpression affects 
the formation of amyloid plaques by crossing them with a mouse model for 
Alzheimer’s disease. 
 
ACTIVITY-INDUCED REGULATION OF NOGO-RECEPTORS AND LOTUS 
It has been known for almost a decade that NgR1 expression can be downregulated by 
activity and it has also been shown that NgR1 expression is regulated in a variety of 
different settings (Endo et al., 2007; Josephson et al., 2003; Karlen et al., 2009; Wills et 
al., 2012). While most evidence suggests that NgR1 is downregulated following 
situations associated with increased neural activity and plasticity, it was recently shown 
that NgR1 mRNA and protein was upregulated in a rat stroke model, increasing the 
complexity of NgR1 expression regulation (Cheatwood et al., 2008). In this study, we 
subjected mice to Kainic acid and analyzed NgR1 expression and compared results to 
the earlier publication from our lab (Josephson et al., 2003). We included more time 
points as well as an analysis of regional levels of mRNA encoding of NgR2, NgR3 and 
the endogenous NgR1 antagonist LOTUS. We investigated four regions of interest that 
are all implicated in memory formation and associated with high synaptic plasticity 
CA1, CA3, the dentate gyrus and the retrosplenial cortex. Hippocampus has long been 
known to be important for memory and the retrosplenial cortex is also highly associated 
with both memory and cognition (Vann et al., 2009).  
 
In CA1 of hippocampus the levels of both NgR2 and LOTUS mRNA were highly 
stable and showed minimal modulation after Kainic acid administration (NgR2 was 
significantly but minimally downregulated after 12 h). In contrast, NgR1 mRNA was 
significantly downregulated after 4 h while the expression of NgR3 mRNA was 
strongly upregulated at 4 h and maintained until 12 h. The expression of LOTUS 
mRNA was stable in the CA3 region of hippocampus, suggesting that LOTUS levels in 
hippocampus proper are not significantly regulated by Kainic acid injection. NgR2 and 
NgR3 mRNA levels were both increased in CA3 at 4-12 h. This upregulation was 
significant for NgR3 but not for NgR2 (presumably due to high inter-individual 
variability). The expression pattern of NgR1 in CA3 was very similar to that seen in 
CA1 and NgR1 mRNA was significantly downregulated at both 2 and 4 h, by 12 h 
expression had returned to control levels. Interestingly, LOTUS, that did not show any 
regulation by Kainic acid in CA1 or CA3, was strongly upregulated in the dentate gyrus 
with a peak in expression seen at 12 h. In addition, both NgR2 and NgR3 mRNA levels 
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were upregulated in the dentate gyrus, peaking at the 4h mark for NgR3 and at 12 h for 
NgR2. Compared to NgR2, NgR3 and LOTUS, the levels of NgR1 mRNA expression 
showed a very different regulation after Kainic acid in the dentate gyrus with a 
significant decrease peaking already at 2 h. The expression patterns in the retrosplenial 
cortex were much more stable than those seen in hippocampus and the dentate gyrus. 
None of the tested genes showed any significant regulation in this area, instead 
expression patterns were remarkably stable during the 72 h period examined (with the 
exception of NgR3). 
 
The fact that the regulation of the different Nogo-receptors show temporal and spatial 
differences is highly interesting, especially as they differ markedly in ligand affinity. 
NgR2 can bind MAG but not Nogo or OMGP. NgR3, on the other hand, completely 
lacks affinity to all of the known myelin inhibitors (MAG/OMgp/Nogo) but was 
recently shown to have affinity for chondroitin sulfate proteoglycans (CSPGs) 
(Dickendesher et al., 2012). Thus the current knowledge suggest that while both NgR2 
and NgR3 only bind to a specific subset of ligands, NgR1 can bind to all of the known 
myelin inhibitors (MAG/OMgp/Nogo) as well as to CSPGs (Dickendesher et al., 2012). 
Hence it is possible that downregulation of NgR1 and increased expression of NgR2 
and NgR3 will result in changes in how a neurite relates to its local environment 
through Nogo, MAG, OMgp and CSPGs. Enhanced NgR2 and NgR3 activity could 
serve to maintain or enhance sensitivity to MAG and CSPGs, while the downregulation 
of NgR1 could result in a decrease in the sensitivity to Nogo-A (and OMgp); as Nogo-
A is also expressed in neurons this could result in a decrease of neuron-neuron 
inhibition, while myelin-neuron inhibition would remain high, with the result being that 
local gray matter sprouting could increase without affecting growth of non-terminal 
axons. The marked and dentate-specific increase of LOTUS mRNA may serve to 
further block Nogo sensitivity of activated neurites in this region, thus permitting new 
memories to leave a trace in the hippocampal formation. 
 
In a recent publication it was shown that NgR2 and NgR3 could be downregulated 
following activation in dissociated hippocampal cell cultures using either (NMDA or 
KCl) (Wills et al., 2012). The reason for this difference in regulation is not presently 
known, but could be dependent on either the induction method (NMDA/KCl vs. Kainic 
acid) or be a due to a difference in response between neurons in cell culture and 
neurons in vivo.  
 
CREATION OF NGR1 OVEREXPRESSING MICE  
To investigate if downregulation of NgR1 is of importance in memory formation, we 
created a mouse with inducible overexpression of NgR1. In the MemoFlex mouse the 
expression of NgR1 is controlled by the CamKII promoter and utilizes the Tet-off 
system, hence NgR1 is overexpressed in forebrain neurons and can be turned off by 
adding doxycycline to the drinking water. Two different lines of MemoFlex mice, that 
both showed similar but somewhat different overexpression patterns (varying mainly in 
the intensity of overexpression), were used in subsequent studies. For L1 there was a 
substantial overexpression of NgR1 seen throughout the cerebral cortex and striatum, 
including nucleus accumbens. There was also strong transgene expression in 
hippocampus proper and the neighboring dentate gyrus, as well as in amygdala. Mice 
from L2 showed similar expression patterns to L1 mice with very strong 
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overexpression in striatum and the cerebral cortex. The transgene expression in the 
hippocampus, and dentate gyrus was however a lower than that seen in L1 mice, while 
amygdala levels were rather high (Fig 1).  
 
 
 
 
 
 
 
  
Figure 1. Expression of NgR1 transcripts in MemoFlex mice of Line 1 and 2 
Expression is shown at two different levels (striatum and hippocampal). The left column 
at each level shows total NgR1 levels, the middle column shows endogenous and the 
right column shows transgene-specific expression. 
 
Figure 2. Protein 
expression of NgR1 in 
MemoFlex and control 
mice 
MemoFlex mice of Line 1 
have a high over-
expression of NgR1 
protein. This over-
expression can be returned 
to basal levels after 
doxycycline treatment for 
9 days. 
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To verify that the increased mRNA expression also correlated with an increase in 
protein levels  we used western blots and could see a strong overexpression of NgR1 
protein in the same areas (Fig 2) as seen in the in situ analysis (hence levels of protein 
and mRNA were correlated). We also wanted to confirm that addition of doxycycline 
could turn off overexpression and thereby reduce NgR1 levels.  As can be seen in Fig 2, 
already after 3 days of doxycycline treatment the levels of NgR1 had dropped 
significantly and after 9 days of doxycycline expression, NgR1 expression was similar 
to that seen in control animals.  
 
MEMOFLEX MICE HAVE NORMAL LOCOMOTOR BEHAVIOR  
We next examined the locomotor behavior of MemoFlex mice using two different 
methods. We first analyzed the coordination and basal locomotor abilities of our mice 
using the accelerating Rotarod. The time that the mice managed to stay on the Rotarod 
was recorded and in this test, MemoFlex mice did not show a significant difference in 
time compared to control mice, suggesting that they do not have impairments in 
locomotion or in coordination (Fig 3 A). To further analyze their behavior we analyzed 
basal locomotor activity of MemoFlex and control mice using the AccuScan apparatus. 
MemoFlex mice performed similarly to control mice (Fig 3 B, C) in this test as well. 
Hence, overexpression of NgR1 does not appear to affect locomotor activity, 
coordination or explorative behavior. The fact that basal locomotor function is intact in 
MemoFlex mice is of profound importance as most memory tests performed on mice 
requires both locomotion and normal exploratory behavior.   
 
 
 
 
  
Figure 3. MemoFlex mice show normal locomotor behavior and co-ordination 
A, MemoFlex mice were tested in the Rotarod test and showed very similar behavior 
compared to controls.  
B and C, MemoFlex mice had very similar locomotor behavior compared to controls 
as recorded in activity boxes, suggesting that basic locomotor function and 
explorative behavior is normal in MemoFlex mice. 
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DAY TO DAY LEARNING IS INTACT IN MEMOFLEX MICE  
To test if NgR1 overexpression would affect memory formation we subjected 
MemoFlex mice to two different memory tests, the Morris water maze and passive 
avoidance.  The Morris water maze consists of a large circular tank, filled with water, 
with a submerged hidden platform in one of the four quadrants. Mice will learn to find 
the platform to escape from the water and the speed with which they find the platform 
can be used as a measure of their spatial memory skills.  
 
MemoFlex mice from both L1 and L2 performed very similar to controls (Fig 4) and 
improved their performance in the task in a similar manner as controls. As swim speed 
can have a profound effect on the performance of mice in the Morris water maze we  
 
 
  
Figure 4 MemoFlex exhibit normal learning in the Morris Water maze 
MemoFlex mice could learn the Morris water maze equally well as control mice 
and showed similar day to day gains. 
 
 
 
 
 
 
Figure 5. Normal probe trial 
performances by MemoFlex mice 
MemoFlex mice showed similar 
preference for the platform containing 
quadrant during the probe trial 
(platform removed).  
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compared the swim speed for the two groups and did not find any significant difference 
between controls and MemoFlex mice.  The Morris was intended as a test of 
hippocampal function but mice can solve the maze using a variety of different 
strategies. Instead of using a hippocampal based strategy (using the external cues) mice 
can use a strategy based on procedural memory (swimming at a certain distance from 
the wall). To control for this, we performed a probe trial at day 8 (platform removed) 
and analyzed how much time MemoFlex mice spent in the quadrant that used to 
contain the platform compared to controls (Fig 5). There was no significant difference 
in the performance between MemoFlex mice and controls, strongly suggesting that 
MemoFlex mice can learn the Morris water maze equally well as controls and that they 
learn it using a hippocampus dependent strategy.  
 
We also tested the mice using the passive 
avoidance test. In this test mice are put into the 
light compartment of a two compartment box 
(one light side, one dark side). During the first 
day the door between the two compartments was 
closed when the mouse was put into the box and 
during the first minute the mouse was allowed to 
explore the light compartment. After 1 minute 
the door opened and allowed access to the dark 
side, and when the mouse crossed over (to the 
dark side) the door closed and a light foot shock 
was administrated. The mouse was then 
reintroduced to the chamber at various later time-
points and their latency to enter the dark 
compartment was measured as a score of the 
strength of the fear memory. When MemoFlex 
mice and controls were retested again 24h after 
the training session there was no difference in 
the performance between control and MemoFlex 
mice (Fig 6). Supporting the notion that 
overexpression of NgR1 does not impair the 
formation of day to day memory. Hence we 
could show, using two different memory 
paradigms, that  MemoFlex mice are not only 
able to learn the memory tasks but that they can 
do so equally well as controls. In fact in almost 
all tests the performance of MemoFlex mice was 
remarkably similar to that of controls. We 
therefore conclude that overexpression of NgR1 
in forebrain neurons does not impair day to day 
memory. 
 
 
 
 
 
Figure 6. Normal 24 h passive 
avoidance memory in MemoFlex mice   
When MemoFlex mice of L1 and L2 
were tested in the Passive avoidance test 
24 h after training their performance was 
not significantly different from controls.  
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MEMOFLEX MICE HAVE NORMAL LTP INDUCTION  
We hypothesize that NgR1 should be involved in the synaptic plasticity that underlie 
long-term memory storage but that this would be on a longer time scale than those 
events that initiate and maintain LTP. To measure LTP, we recorded extracellular field 
EPSPs from CA1 in hippocampal slices from control as well as from L1 and L2 
MemoFlex mice following 0.033-Hz electrical stimulation. The experiment started with 
10 min of stable baseline recordings after which LTP was induced using either high 
frequency or theta-burst stimulation (Fig 7 A and B) that lasted at least 70 min. No 
significant difference was seen between MemoFlex and control mice suggesting that 
NgR1 down-regulation is not required for LTP induction.  
 
To verify that baseline synaptic processes were not affected, fEPSP from control and 
MemoFlex mice were analyzed and found to have similar time courses and shapes (Fig. 
7 A and B), and similar responses across a range of stimulus intensities (Fig. 7 F). 
Hence it appears that baseline synaptic properties were not altered by NgR1 
overexpression.  
 
It is possible that while MemoFlex mice could induce LTP it would not be stable for 
prolonged time periods. We therefore tested this by following slices for 2h and found 
stable LTP maintained during this entire period using a single theta burst stimulation, 
and there was no significant difference between control and L2 mice (Fig. 7 C) (P 
=0.54, two-way RM-ANOVA, genotype*time).  
 
Loss of NgR1 has been shown to prevent LTD induction in the hippocampus (Lee et 
al., 2008). As LTD is normally only observed in slices obtained from juvenile animals 
(Wagner and Alger, 1996) it is unlikely that it would underlie any long-term behavioral 
changes observed in our adult mice. However, reversal of LTP (de-potentiation) by low 
frequency stimulation (LFS) is well known to occur in adult animals (Staubli and 
Scafidi, 1999), and has also been shown to reverse changes in spine morphology 
induced by LTP (Yang et al., 2008). Therefore we investigated if there was a difference 
in de-potentiation between MemoFlex and control animals.  Two different paradigms 
(300 or 900 pulses) of LFS (1 Hz) were administrated 5 min after theta burst 
stimulation and both resulted in de-potentiation of the induced LTP. De-potentiation 
was dependent on the number of stimuli, 300 (Fig 7 D) vs. 900 pulses (Fig 7 E) but 
MemoFlex mice did not differ compared to control mice in any of the protocols (300 
pulse, P=0.55; 900 pulse, P=0.82; two-wayRM ANOVA, genotype*time).  
 
These data strongly suggest that MemoFlex mice do not have any significant intrinsic 
deficits in electrophysiological hippocampal plasticity. 
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Figure 7. Normal LTP in MemoFlex mice 
A and B, LTP induction using HFS or theta-burst stimulation was not changed in 
MemoFlex mice. 
C, LTP was comparable between MemoFlex and controls even at longer time-points 
D and E, De-potentiation using 300 or 900 pulses respectively did not reveal a 
difference between MemoFlex and control mice. 
F, Synaptic properties are not changed in MemoFlex mice as tested during a variety 
of stimulus intensities.  
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NGR1 OVEREXPRESSION IMPAIRS LASTING MEMORIES  
While day to day memory was intact in MemoFlex mice, we hypothesized that lasting 
memory would be affected by overexpression. We therefore tested the mice that had 
performed the Morris Water maze in Fig (4) nearly two months after their last training 
day. In this experiment the platform was at the same position as during the learning 
phase, hence good performance in this maze would require the mice to remember the 
position of the platform. Strikingly, MemoFlex mice were severely impaired in this test 
compared to the control mice and needed significantly longer time to find the platform 
(Fig 8 B). MemoFlex mice also spent significantly less time in the quadrant containing 
the platform, again indicating impaired memory of platform location (Fig 8 A).  
 
 
 
 
 
 
 
 
A second group of mice were tested in the Morris water maze with a probe trial at 39 
days and performed similarly to the first group of MemoFlex mice, significantly worse 
than controls (Fig 8 C). Hence while MemoFlex mice are not impaired in their 
Figure 8. Impaired lasting memories in MemoFlex mice in the Morris water maze 
A, percent time spent in platform-containing quadrant 60 days after learning was 
significantly impaired in MemoFlex mice. 
B, the escape latency was increased in MemoFlex mice, at day 60. 
C, in a second group of mice a probe trial was performed at day 39 and also in this test 
MemoFlex mice were significant impaired. 
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performance during the learning phase of the Morris water maze their performance is 
severely impaired after a prolonged waiting period between learning and retest.  
 
We also tested lasting memories in MemoFlex mice that had been trained in the passive 
avoidance test. As described previously, MemoFlex mice showed similar aversion to 
the dark compartment as controls, hence there contextual fear condition learning 
appeared to be normal. When the same animals were exposed to the passive avoidance 
apparatus after one month the control mice exhibited significantly stronger aversion to 
the dark compartment than MemoFlex mice (Fig 9 A). To verify that the difference 
between the groups were specific for NgR1 overexpression and not due to NgR1 
induced developmental disturbances we gave a group of mice doxycycline before (3 
weeks) and during the experiment, to remove NgR1 overexpression. Both L1 and L2 
MemoFlex mice were used in this experiment and both groups now performed similar 
to control mice indicating that NgR1 overexpression from birth does not result in any 
major learning disabilities as performance is normalized when overexpression is turned 
off in adulthood (Fig 9 B). In a second experiment we wanted to further analyze the 
time window during which NgR1 overexpression impairs formation of lasting 
memories. To test this, two groups of mice were given doxycycline starting either 
directly or 7 days after the training day. The passive avoidance boxes used in this 
experiment were slightly different than those used in the first experiment; instead of  
  
Figure 9. Impaired lasting memories in the Passive avoidance test can be rescued 
with doxycycline 
A, MemoFlex mice were significantly impaired when tested 1 month after the training 
session.  
B, this impairment could be rescued by adding doxycycline to the drinking water 3 
weeks before the start of the experiment. 
C, the effect could also be reversed by adding doxycycline immediately after the 
training session but not when it was added after 7 days. 
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measuring the latency to enter the dark compartment the time spent in the dark 
compartment was measured. Interestingly, while the group that received doxycycline 
directly after the training normalized their performance and were not significantly 
different from controls when tested 1 month after training, MemoFlex mice that 
received doxycycline starting 7 days after the training phase were still significantly 
impaired in this test (Fig 9 C).  
 
While NgR1 overexpression does not impair memory formation during day to day 
learning, the effects on lasting memory are significant and results in a severe 
impairment. Furthermore, this impairment in memory function can be reversed if 
doxycycline is given before or at the start of the experiment, indicating that NgR1 
overexpression does not result in any major developmental disturbances. However, if 
doxycycline is given 7 days after the learning event, memory impairments will still be 
evident suggesting that high NgR1 levels during the first few days following the 
training paradigm can impair memory formation and that this cannot be rescued by 
reducing protein levels later on. As discussed earlier, if doxycycline is administrated in 
the drinking water the overexpression of NgR1 is reduced after 3-9 days and therefore 
suggesting that NgR1 downregulation is most important rather early after memory 
induction. Retrograd amnesia after concussion typically spans the last week before the 
concussion, roughly compatible with the time during which NgR1 down-regulation is 
needed for lasting memories to become consolidated. 
 
NGR1 AND PLAQUE DEVELOPMENT 
It has been shown that NgR1 (Park et al., 2006a; Park et al., 2006b) as well as NgR2 
and NgR3 (Zhou et al., 2011) can bind to amyloid precursor protein (APP). However, 
there are conflicting reports concerning the exact effect of Nogo-receptor interaction 
with APP. According to the two studies by Park et al (Park et al., 2006a; Park et al., 
2006b) NgR1 knock-out mice show an increase in plaque load when crossed with an 
animal model of Alzheimer’s disease (APPswe/PSEN1). Furthermore, when 
APPswe/PSEN1 mice received soluble NgR1 subcutaneously the plaque load 
decreased and the impaired performance of APPswe/PSEN1 mice in a radial arm water 
maze was also attenuated, in fact after the mice started to receive soluble NgR1 their 
performance improved and moved towards that seen in control mice. A recent study 
has also shown that NgR1 can bind to APP, but it does so with less affinity than NgR2 
and NgR3 and contrary to the studies by Park and colleagues., Zhou and colleagues  
(Zhou et al., 2011) found that overexpression of Nogo receptors resulted in an increase 
in Aβ-production not an decrease. Hence while it appears clear that the Nogo-receptors 
have affinity for APP, their exact function remains somewhat elusive. To investigate 
this further we crossed our MemoFlex mice (L1) with the same Alzheimer’s mouse 
model (APPswe/PSEN1) as used in the previous studies.  
 
 
 
MEMOFLEX/APPSWE/PSEN1 MICE SHOW OVEREXPRESSION OF NGR1  
We first wanted to confirm that crossing these two mouse lines would in fact lead to 
increased expression of NgR1 and that the expression would be strong in the regions 
that are associated with plaque formation. As expected, crossing MemoFlex mice with 
APPswe/PSEN1 mice resulted in a strong overexpression of NgR1 in the same regions 
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as seen in the MemoFlex mouse and these regions are also highly affected by plaque 
deposition both in humans and in APPswe/PSEN1 mice (Borchelt et al., 1997; Hardy 
and Selkoe, 2002; Selkoe, 2005). The MemoFlex/APPswe/PSEN1 mouse showed 
much stronger expression of NgR1 in cortex (Fig 10 A) compared to that seen in the 
APPswe/PSEN1 mouse (Fig 10 B). The expression was strong and uniform throughout 
cortex and could be seen in all different cortical layers. NgR1 was also strongly 
overexpressed in hippocampus and the dentate gyrus (Fig 10 C) and even tough 
APPswe/PSEN also show robust labeling in hippocampus and the dentate gyrus (Fig 10 
D), it was clearly lower than that seen in MemoFlex/APPswe/PSEN1 mice.  
 
 
 
 
 
NGR1 OVEREXPRESSION DOES NOT DECREASE PLAQUE 
To analyze if NgR1 overexpression influenced the plaque load we stained tissue for Aβ 
and analyzed the area covered by plaques as well as the number of individual plaques. 
This was done in two different areas, the cerebral cortex and hippocampus, both 
regions that show high levels of Aβ in human Alzheimer patients (Hardy and Selkoe, 
2002; Selkoe, 2005). We analyzed mice at an average age of 72 weeks and could not 
find any significant difference in plaque load (Fig 11 A) or in the number of plaques in 
the cerebral cortex (Fig 1 B). The same analysis was performed in the hippocampus and 
similarly to the cerebral cortex we could not find any significant difference in plaque 
load (Fig 11 C) or the number of plaques (Fig 11 D).   We also analyzed if the rate of 
plaque development was different between the two different groups; to do this we 
added animals with a wider spread in age to the group analyzed previously and plotted 
plaque load compared to age for MemoFlex/APPswe/PSEN1 and APPswe/PSEN1 
mice for the cerebral cortex (Fig 11 E) and hippocampus (Fig 11 F). Both groups were 
Figure 10. Strong overexpression of 
NgR1 in MemoFlex/APPswe/PSEN1 
mice 
A, expression of NeuN and NgR1 in the 
cortex of MemoFlex/APPswe/PSEN1 
mice. 
B, the expression of NeuN was similar in 
APPswe/PSEN1 mice while NgR1 levels 
are substantially lower. 
C, expression of NeuN and NgR1 in the 
dentate gyrus of 
MemoFlex/APPswe/PSEN1 mice. 
D, again the expression of NeuN was 
very similar in APPswe/PSEN1 mice but 
the levels of NgR1 were much lower. 
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still very similar and hence we can conclude that neuronal overexpression of NgR1 
does not decrease the formation or deposition of plaques in the APPswe/PSEN1 mice.  
 
The fact that very little difference was seen in any measure of the plaques supports the 
conclusion from Zhou and colleagues that NgR1 does not appear to be a strong effector 
of Aβ processing. This however does not rule out the possibility that soluble NgR1 
could work as a peripheral sink when administrated I.P.  
 
 
Figure 11. No change in plaque levels in MemoFlex/APPswe/PSEN1 mice 
A and B, the area covered by plaques and the numbers of plaques were not significantly 
different in MemoFlex/APPswe/PSEN1 mice 
C and D, Similarly to the situation in cerebral cortex, no significant difference could be seen 
in the hippocampus 
E and F, time-course of plaque development is very similar in MemoFlex/APPswe/PSEN1 
and APPswe/PSEN1 mice. 
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MEMOFLEX/APPSWE/PSEN1 MICE ARE IMPAREID IN MORRIS WATER 
MAZE  
We next investigated if NgR1 overexpression would influence the performance of mice 
in the Morris water maze. While NgR1 overexpression does not appear to influence 
plaque load in APPswe/PSEN1, 29 week old MemoFlex/APPswe/PSEN1 mice were 
significantly impaired (Fig 12 A, Genotype p = 0.004, Day p < 0.001, and Genotype 
*Day = 0.252) compared to APPswe/PSEN1 mice in the learning phase of the Morris 
water maze (Fig 12 A). After the 7 day learning paradigm we also performed a probe 
trial at day 8 (Fig 12 B) and even though there were no significant difference between 
the groups, the performance of the MemoFlex/APPswe/PSEN1 mice tended to be 
worse (p = 0.096) suggesting that their knowledge of the platform location could be 
impaired.  
 
We also retested these mice at an age of 50 weeks to see if the difference would 
increase with time. As MemoFlex mice have impaired long lasting memory we moved 
the platform to a new location to minimize any beneficial effects of remembering the 
old platform location. At an age of 50 week we could see the same trend as previously, 
MemoFlex/APPswe/PSEN1 had impaired performance in the maze compared to 
controls (Fig 12  C, Genotype p = 0.004, Day p = 0.001, Genotype*Day = 0.116). At 
the probe trial performed on day 8 there was no significant difference between the two 
groups (Fig 12 D, p=0.17) 
 
We next wanted to analyze if the mice were affected differently during the 20 week that 
separated the 29 and 50 week test. We therefore combined the data from week 29 and 
week 50 in a single analysis. There was a significant effect of week (p=0.019) showing 
that the animals performed better at week 50 compared to week 29, possibly due to the 
fact that they were already familiar with the maze. There was also a strong effect of 
genotype (p = 0.001) but there was no significant interaction with genotype 
(genotype*week p=0.265), hence both groups changed in a similar manner with time. 
We performed the same analysis with regard to the probe trials and in the combined 
analysis we could see a significant effect of genotype (p=0.02) but there was no effect 
of week (p=0.865) and hence performance was very similar on week 29 as it was on 
week 50 and similarly to what was seen for the learning curve there was no interaction 
between genotype and week (p=0.867).  
 
To confirm that the worse performance of MemoFlex/APPswe/PSEN1 mice was due to 
cognitive deficits and not due to motor problems, we also analyzed swim speed and 
thigmotaxic behavior. There was no significant difference in the swim speed (Fig 12 E) 
between MemoFlex/APPswe/PSEN1 and APPswe/PSEN1 mice at week 29 (p=0.22) or 
at week 50 (p=0.46). Both MemoFlex/APPswe/PSEN1 and APPswe/PSEN1 mice 
showed very similar thigmotaxic behavior (Fig 12 F) at week 29 (p=0.81) and at week 
50 (p=0.35). Therefore it is unlikely that a difference in search strategy would explain 
the difference that we found between the two groups. Instead it appears that 
overexpression of NgR1 in APPswe/PSEN1 impairs the spatial cognitive abilities 
without affecting plaque load or numbers. One possible reason could be that higher 
than normal expression of NgR1 could result in impairments in compensatory synaptic 
plasticity (Hashimoto and Masliah, 2003) that is suggested to compensate for the 
damaged caused by the disease. It has in fact been shown that knocking out Nogo-A 
can improve performance of APPswe/PSEN1 mice without affecting plaque load 
presumably trough increasing the ability for compensatory plastic changes (Masliah et 
al., 2010). Also, while MemoFlex/APPswe/PSEN1 mice did not have significantly 
higher plaque load in any of the tests, their levels were always higher than that of 
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controls in all analysis and it is cannot be ruled out that the difference, while not 
significant, still could have an impact on behavior.  
 
 
 
 
 
 
Figure 12. Impaired performance in the Morris water maze for 
MemoFlex/APPswe/PSEN1 mice 
A, MemoFlex/APPswe/PSEN1 mice showed significantly worse learning than controls in the 
Morris water maze at 29 weeks of age. 
B, they also had a tendency of impaired performance in the probe trial. 
C, the performance was also impaired at 50 weeks of age. 
D, they also showed worse performance in the probe trial but it did not reach significance. 
E and F, thigmotaxis and swim speed was not impaired due to overexpression. 
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NORMAL RADIAL ARM WATER MAZE IN MEMOFLEX/APPSWE/PSEN1 
MICE  
A second group of animals performed the radial arm water maze (RAWM) instead of 
the Morris water maze at three different time-points (16, 24 and 28 weeks of age). The 
RAWM differ from Morris water maze in that instead of a big open platform the 
RAWM consists of a small open center area with 6 arms protruding from it. In one of 
the 6 arms there will be a hidden platform and the other 5 arms will serve as starting 
arms. There was no significant difference between the two groups of animals in any of 
the 3 different time points tested (Fig 13 A-C), 16 weeks (Fig 13 A, genotype p = 
0.102, day p < 0.001 genotype*day p = 0.977), 24 weeks (Fig 13 B, genotype p = 0.963 
day p < 0.001, genotype*day p = 0.307) and 28 weeks (Fig 13 C, genotype p = 0.248, 
day p < 0.001 and genotype*day p = 0.307).  
 
 
 
 
 
Figure 13. Normal performance in the Radial arm water maze for 
MemoFlex/APPswe/PSEN1 mice 
A, B, C. The performance for MemoFlex/APPswe/PSEN1 mice was very similar to 
that of APPswe/PSEN1 mice during all three different time points. Even though both 
groups performed worse with time, they did so at a similar rate. 
D, a second group of mice were also tested in the radial arm water maze was also in 
this test the performance of MemoFlex/APPswe/PSEN1 mice was indistinguishable 
from that of APPswe/PSEN1 mice. 
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Even though there was no significant difference between the two groups of mice their 
performance significantly worsened with time (week p < 0.001 and week*day p < 
0.001) when all of the time-points were analyzed together. However, both groups of 
animals had similar change with time and there was no genotype*week effect (p = 
0.674) 
 
We also tested a second group of mice (those that later performed the Morris water 
maze) and similarly to the first group there was no significant difference in their 
performance (Fig 13 D) compared to controls (genotype p = 0.875, day p < 0.001, 
genotype*day p = 0.214). The reason for the significant difference seen in the Morris 
water maze could either be that it poses somewhat different demands on the mice than 
the RAWM and/or that the mice that performed the Morris water maze where older and 
it is possible that behavioral differences would occur with time also in the RAWM.  
 
MEMOFLEX MICE SHOW INCREASED SENSITIZATION  
As we have previously shown that NgR1 overexpression impairs the formation of 
lasting memories of both spatial and fear based types, we wanted to investigate if the 
role of NgR1 could be even more general. A second type of long term adaptation that 
can occur in the brain is that caused by drugs of abuse. Once a person becomes 
addicted to a drug of abuse, the addiction will generally be lifelong. Hence, whatever 
changes that occur must be very stably stored in the brain and also be rather substantial. 
One of the most well studied paradigms of the effects of drugs is a process called 
sensitization. When animals are repeatedly injected with psycostimulants such as 
amphetamine, their response will increase with time (Segal and Mandell, 1974), even 
when the dose is held constant. Thus their response becomes sensitized and these 
effects can be very stabile, lasting over a year in rodents and for several years in 
monkeys (Castner and Williams, 2007). We therefore wanted to investigate if 
overexpression of NgR1 would affect the long lasting stability of sensitization.  
 
We began by subjecting MemoFlex mice and controls to a 9 day sensitization 
paradigm. In our setup mice first received saline injections for 2 days to establish a 
baseline and after the initial two days they received amphetamine injections for 7 
consecutive days Fig 14 (A). The performance of MemoFlex (L1) and control animals 
were similarly during the first 2 days of saline injections. However, during the 7 days of 
amphetamine administration a significant difference in the development of the 
sensitization response could be seen. MemoFlex mice became significantly more 
sensitized compared to controls (Genotype p= 0.5, Day < 0.001 and 
Genotype*Day=0.017). While control mice level off after 3-4 days of sensitization, 
MemoFlex mice continue to increase their locomotor activity throughout the 
experiment. To further analyze the difference in sensitization behavior we also 
analyzed the amount of time the mice spent moving (Fig 14 D) and this correlated very 
well with the distance moved. Hence the difference was due to an increase in moving 
time and not a difference in movement speed. One factor that can greatly influence the 
amount of locomotion animals exhibit is amount of stereotypies (repetitive motions). 
This was analyzed and both groups exhibited similar levels of stereotypies and it is 
therefore unlikely that the level of stereotypy would significantly affect the difference 
that was seen between the groups in the development of sensitization. 
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We next wanted to see if the difference in sensitization could be rescued by adding 
doxycycline to the drinking water (starting three weeks before the start of the 
experiment). When doxycycline was added and hence NgR1 levels normalized, then so 
did the sensitization behavior (Fig 14 B) and the behavior of MemoFlex mice was not 
significantly different from that of controls. As seen in the previous groups, locomotor 
behavior correlated very well with movement time (Fig 14 E), suggesting that 
movement speed was very similar between the different groups. There was no 
significant difference in the amount of stereotypies either (Fig 14 H). 
 
As an increase in the amount of NgR1 expression resulted in an increase in 
sensitization, we wanted to see if lower levels of NgR1 would result in a decrease in 
sensitization. We therefore subjected a group of NgR1 knockout mice (NgR1-/-) to the 
same sensitization paradigm with heterozygote NgR1 mice (NgR1+/-) as controls. 
There was no significant difference between NgR1-/- and NgR+/- mice during the 
sensitization paradigm. Instead, they performed very similar with regard to both 
distance (Fig 14 C) and movement time (Fig 14 F). There was no significant difference 
in the amount of stereotypy between the groups and even if the levels were somewhat 
higher in the NgR1-/- group, it is unlikely that this would mask a significant difference 
in locomotor behavior. It is thus reasonable to assume that loss of NgR1 have small if 
any effects on the development of a sensitization behavior.  
 
It thus appears that overexpression of NgR1 results in a large increase in sensitization 
because MemoFlex mice are unable to counteract sensitization and such that the 
amphetamine responses level off after 3-4 days as is normally the case. This difference 
is due to the expression of NgR1 protein during the sensitization paradigm and not due 
to developmental disturbances as doxycycline treatment during the sensitization 
paradigm normalizes the behavior of MemoFlex mice. Finally, the fact that  complete 
loss of NgR1 does not affect the development of a sensitization, suggests that  
activation induced by amphetamine is strong enough to cause a maximal plastic 
response even in the presence of normal NgR genes, and that thus loss of NgR1 does 
not give any additional plastic benefits in this case.  
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Figure 14. MemoFlex mice have increased sensitization compared to controls that 
can be normalized with doxycycline 
A, D, G MemoFlex and control mice received saline for the first 2 days followed by 
amphetamine (2mg/kg) for 7 days and locomotion (A), moving time (B) and 
stereotypy times (C) were measured. MemoFlex mice showed increased sensitization 
but comparable stereotypy. 
B, E, H when doxycycline was added to the drinking water the performance of 
MemoFlex mice normalized 
C, F, I the sensitization of NgR1-/- mice was not altered compared to NgR1+/- mice. 
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LONG TERM SENSITIZATION IS REDUCED IN MEMOFLEX MICE  
As the important effects of NgR1 overexpression has been seen on lasting memory, we 
wanted to see if the effect of the locomotor sensitization would decrease with time in 
MemoFlex mice while remaining stable in control mice. We therefore re-exposed the 
mice to amphetamine 1 and 3 months after the last day of sensitization. MemoFlex 
mice showed a significant decrease (p=0.041) in their locomotor behavior with time 
(Fig 15 A) while control mice had a tendency increased locomotor response with time 
(p=0.52 last day to 3 months later).  
 
The mice that performed the sensitization experiment on doxycycline were kept on 
doxycycline and re-tested 1 and 3 months after the end of the sensitization paradigm. 
For both groups there was no significant effect of time. After one month the 
performance was very similar for both groups and after 3 months a small but non-
significant drop was found in the MemoFlex mice and the tendency for an increase that 
was seen in the controls without doxycycline (Fig 15 B) could not be seen. It therefore 
appears that giving mice doxycycline largely stabilizes the long term sensitization but 
that some residual impairment might still be found. It is also possible that the long 
treatment time with doxycycline (around 4 months in total) could have an effect in 
itself.  
 
NgR1+/- and NgR1-/- mice showed very similar long term response to amphetamine 
exposure but the changes seen were larger in NgR1-/- compared to NgR1+/- mice (Fig 
15 C). NgR1-/- mice exhibited a significant increase in their sensitization response 
when re-exposed to amphetamine 1 month after their last injection, but when retested 3 
months after the learning phase their sensitization level was back to that seen 
immediately after the end of the sensitization paradigm. NgR1+/- mice had a stable 
response to the sensitization paradigm and did not show any significant change with 
time.  
 
We conclude that NgR1 overexpression impairs lasting memory function in a wide 
array of different settings and that removing NgR1 overexpression in adulthood largely 
normalizes the mice with respect to memory function. In contrast, while NgR1-/- mice 
have been shown have increased plasticity,  for instance a monocular deprivation task 
(McGee et al., 2005) it is possible that NgR1 levels are normally held and regulated in a 
way that does not require additional downregulation to function satisfactorily. It is 
however interesting that NgR1-/- mice showed an increase in sensitization after 1 
month that later reverted at 3 months. It is possible that NgR1-/- mice indeed are more 
plastic in this setting and that the high plasticity could also enhance extinction or 
relearning.  
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NGR1 OVEREXPRESSION AFFECTS SPINE DYNAMICS  
The development of a sensitization behavior is closely linked to changes in spine 
structure and density (Luscher and Malenka, 2011; Robinson and Kolb, 2004; Russo et 
al., 2010). We therefore wanted to evaluate if NgR1 overexpression would affect spine 
density following amphetamine treatment.  
 
To investigate how NgR1 overxpression would affect spine density following 
amphetamine exposure, we subjected mice to 7 daily injections of amphetamine (same 
amount of amphetamine as during the sensitization experiment). We first analyzed the 
spine density at the distal part of the apical dendrite of pyramidal neurons in the 
cingulated gyrus. Control mice showed a tendency of an increase in spine density of 
Figure 15. Impaired long term 
sensitization in MemoFlex mice 
A, MemoFlex mice showed a 
decrease in their sensitization from 
the last day of sensitization until 
they were retested 3 months later. 
B, MemoFlex mice with 
doxycycline did not show any 
significant change in sensitization 
over time but the inter-animal 
variance was also high. 
C, NgR1-/- mice had a significant 
increase in sensitization 1 month 
after the sensitization paradigm but 
this disappeared before the 3 month 
time point.  
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around 10% (p=0.079) while MemoFlex mice instead showed a significant decrease in 
spine density (p=0.003) following amphetamine treatment (Fig 16 A). To further 
analyze how NgR1 affected spine morphology, we also analyzed the number of thin 
(Fig 16 B) and mushroom spines (Fig 16 C). Amphetamine resulted in a significant 
decrease in thin spines for MemoFlex mice (p=0.006) on amphetamine compared to 
saline treated MemoFlex mice.  For mushroom spines there was no significant effect of 
either treatment or genotype (Fig 16 C). 
 
 
 
We also analyzed the spine density on medium spiny neurons in the shell of nucleus 
accumbens and could not see any effect on spine density after amphetamine in control 
or MemoFlex mice (Fig 16 D). However, when we analyzed thin (Fig 16 E) and 
mushrooms spines (Fig 16 F) individually, we could see that control mice had a 
decreased number of mushroom shaped spines following amphetamine treatment 
(p=0.04). The mean amount of thin spines did increase following amphetamine 
treatment of control mice, but this was not significant, most likely the reason why there 
Figure 16. Overexpression of NgR1 affects spine dynamics following amphetamine 
sensitization 
A, B, C control mice showed a tendency to an increase in spine density in the cingulated 
gyrus while MemoFlex mice instead had significantly decreased spine density (A).  
When analyzed per subtype it was shown that this was mostly due to a decrease in thin 
spines (B) while mushroom spines were more stable. 
D, E, F in nucleus accumbens the spine densities were very stable after amphetamine 
injections (D). Looking at spine subtypes we could see a significant decrease in densities 
of Mushroom spines in control mice while MemoFlex mice had very stable spine 
densities.  
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was no effect on overall spine density. In nucleus accumbens spine density and subtype 
distribution was minimally affected by amphetamine for MemoFlex mice; possibly due 
to the fact that NgR1 overexpression locked those synapses in place or that NgR1 
function in nucleus accumbens is of less importance. When looking at the synapse 
distribution after saline injections (that should reflect the normal spine levels in these 
animals) the cortical patterns were very similar between MemoFlex and controls, while 
there is a tendency of more thin and less mushroom spines in striatum.  
 
The difference regarding the effects on NgR1 on the spine changes in cerebral cortex 
are highly interesting. It is well established that exposing animals to repeated injections 
of amphetamine results in changes in spine morphology and density (Luscher and 
Malenka, 2011; Robinson and Kolb, 2004; Russo et al., 2010).  However, synaptic 
plasticity does not only involve the formation of new synapses, elimination of synapses 
is also of profound importance and while increased spine density is often seen in the 
early phases after an event that enhances synaptic plasticity, spine number can decline 
back towards baseline levels without the loss of the memory. Hence, it is possible that 
during a learning event far more new spines will sprout than what is necessary for 
forming the engram and through a selection process only those that form functional 
connections will be saved and the others will be removed. Hence, instead of seeing 
memory encoding as an increase in spine formation, it could be seen as a period of 
increased turnover of spines. In such a setting, increased levels of NgR1 could decrease 
the ability to form new spines but keep the elimination side of the equation equal or 
even increased and thereby resulting in spine loss.  
 
When it comes to the spine changes seen in nucleus accumbens, the effects seen in our 
control mice might at first appear paradoxical. The establishment of new memories is 
generally believed to be in part due to the enhancement of connections between 
neurons and due to strengthening (growing) of spines so that thin spines should be 
converted to thicker more influential spines. With this in mind, it is surprising that we 
see a reduction in the density of mushroom spines in control mice. However, 
development of sensitization is not a one-way street and it is likely that there are 
changes occurring that both enhance and inhibit the establishment of a sensitization 
behavior. In fact it has been shown in several studies that sensitization is followed by a 
period of LTD induction in synapses from the prefrontal cortex in the nucleus 
accumbens (Brebner et al., 2005; Goto and Grace, 2005; Thomas et al., 2001) and 
perhaps this could explain why our control mice level off after a few days of 
sensitization while MemoFlex mice continue to sensitize for the entire sensitization 
period.  
 
   47 
CONCLUDING REMARKS 
The aim of this thesis has been to further characterize the potential role of the Nogo-
system as a regulator of plasticity with a focus on memory systems. We have shown 
that all three Nogo-receptors are regulated by activity in areas of importance for 
memory function (hippocampus). When NgR1 is overexpressed (thereby removing the 
ability to downregulate NgR1), mice have normal day to day memories in both Morris 
Water maze and in passive avoidance tests. Strikingly, when overexpressing mice were 
compared to controls after a long waiting period (> 1 month) their performance was 
significantly impaired. Thus, while inability to downregulate NgR1 in forebrain 
neurons does not impair 24 h memory, such memories do not lead to normal lasting 
memories, suggesting a key role for NgR1 in the consolidation of recently acquired 
memories. This effect appears to be caused by NgR1 overexpression just around the 
learning event, as silencing of the transgenic NgR1 overexpression (using doxycycline) 
just after the learning event could rescue their behavior, while later silencing (after 7 
days) did not. 
 
NgR1 mice exhibit an enhanced sensitization response to amphetamine, compared to 
controls. When overexpression was removed their performance became similar to that 
seen in controls, indicating that NgR1 overexpression can also influence this response. 
However, sensitization was not affected in NgR1-/- mice. When sensitization was 
retested at later intervals NgR1 overexpressing mice showed a reduction of 
sensitization, supporting the notion that Ngr1 overexpression impairs lasting memory. 
Overall, NgR1-/- mice were very similar to controls, suggesting that removal of NgR1 
has limited effects on sensitization behavior. We also analyzed spine structure on 
pyramidal neurons in the cingulate gyrus and on medium spiny neurons (MSN) in the 
shell of nucleus accumbens. In cortex, there was a significant reduction of spine density 
in MemoFlex mice while control mice exhibited a tendency of increased spine density. 
A possible explanation for the reduction in spine density could be that NgR1 
overexpression increases the likely-hood of spine collapse so that in times of a needed 
increase of plasticity (such as during the sensitization phase), the ratio of formation and 
elimination could be altered, leading to a net spine loss. In striatum, spine levels in 
medium spiny neurons where remarkably similar for NgR1 overexpressing mice, while 
control mice showed significant alterations. This suggests that NgR1 overexpression 
reduces synaptic plasticity in medium spiny neurons.  
 
We also investigated if NgR1 overexpression would have an effect on plaque formation 
and found that even though plaque levels were similar to controls, the overexpression 
of NgR1 caused these mice to perform worse in the Morris water maze. A possible 
reason for this deficit could be that NgR1 overexpression reduces the amount of 
compensatory plasticity that can otherwise occur in response to the increasing plaque 
load, and thus aggravate symptoms.  
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